US20190110700A1 - Biological information analysis device, system, and program - Google Patents

Biological information analysis device, system, and program Download PDF

Info

Publication number
US20190110700A1
US20190110700A1 US16/092,167 US201716092167A US2019110700A1 US 20190110700 A1 US20190110700 A1 US 20190110700A1 US 201716092167 A US201716092167 A US 201716092167A US 2019110700 A1 US2019110700 A1 US 2019110700A1
Authority
US
United States
Prior art keywords
blood pressure
exercise
period
indicator
pressure waveform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/092,167
Inventor
Hiroshi Nakajima
Hirotaka Wada
Naoki Tsuchiya
Masaaki Kasai
Eriko KAN
Toru Uenoyama
Keiichi OBAYASHI
Ayako KOKUBO
Yuya Ota
Toshikazu Shiga
Mitsuo Kuwabara
Hironori Sato
Ken Miyagawa
Masakazu Tsutsumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omron Corp
Omron Healthcare Co Ltd
Original Assignee
Omron Corp
Omron Healthcare Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omron Corp, Omron Healthcare Co Ltd filed Critical Omron Corp
Assigned to OMRON CORPORATION, OMRON HEALTHCARE CO., LTD. reassignment OMRON CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TSUCHIYA, NAOKI, KAN, ERIKO, KASAI, MASAAKI, OTA, YUYA, UENOYAMA, TORU, NAKAJIMA, HIROSHI, OBAYASHI, KEIICHI, WADA, HIROTAKA, KOKUBO, AYAKO, KUWABARA, MITSUO, SHIGA, TOSHIKAZU, MIYAGAWA, KEN, SATO, HIRONORI, TSUTSUMI, MASAKAZU
Publication of US20190110700A1 publication Critical patent/US20190110700A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/029—Measuring or recording blood output from the heart, e.g. minute volume
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02116—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave amplitude
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02125—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
    • A61B5/02225—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers using the oscillometric method
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
    • A61B5/02233—Occluders specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02438—Detecting, measuring or recording pulse rate or heart rate with portable devices, e.g. worn by the patient
    • A61B5/0456—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0816—Measuring devices for examining respiratory frequency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1118—Determining activity level
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802—Sensor mounted on worn items
    • A61B5/681—Wristwatch-type devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6824—Arm or wrist
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
    • A61B5/721—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7221—Determining signal validity, reliability or quality
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7278—Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56—Devices for preventing snoring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A61M16/024—Control means therefor including calculation means, e.g. using a processor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
    • G06F1/16—Constructional details or arrangements
    • G06F1/1613—Constructional details or arrangements for portable computers
    • G06F1/163—Wearable computers, e.g. on a belt
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/029—Humidity sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/02141—Details of apparatus construction, e.g. pump units or housings therefor, cuff pressurising systems, arrangements of fluid conduits or circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A61B5/4818—Sleep apnoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683—Means for maintaining contact with the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7253—Details of waveform analysis characterised by using transforms
    • A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0083—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus especially for waking up

Definitions

  • the present invention relates to technology for acquiring useful information from a blood pressure waveform that has been measured.
  • Patent Document 1 JP 2008-61824A discloses that a blood pressure waveform is measured using a tonometry method, and pieces of information such as an AI (Augmentation Index) value, a pulse wave period, a baseline fluctuation rate, sharpness, and an ET (Ejection Time) are acquired from the blood pressure waveform.
  • AI Algmentation Index
  • ET Ejection Time
  • Patent Document 2 JP 2005-532111A discloses that a blood pressure waveform is measured using a wristwatch-type blood pressure meter, in which a mean arterial pressure, a mean systolic pressure, a mean diastolic pressure, a mean systolic pressure indicator, and a mean diastolic pressure indicator are calculated from the blood pressure waveform, and an alert is output when any of these values deviates from a reference value.
  • Patent Document 1 JP 2008-61824A
  • Patent Document 2 JP 2005-532111A
  • the inventors of the present invention have been worked hard to develop a blood pressure measurement device that can accurately measure an ambulatory blood pressure waveform for each heartbeat, and to put such a device into practical use. Through experiments performed on subjects during the development phase, the inventors have found that various kinds of useful information can be extracted from data regarding ambulatory blood pressure waveforms that have been consecutively measured.
  • the present invention aims to provide a novel technology for evaluating the degree of influence of exercise on cardiac function, based on data regarding blood pressure waveforms.
  • the present invention employs the following configurations.
  • a biological information analysis device is an biological information analysis device including: an indicator extraction unit configured to acquire, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise, and extract an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and characteristics of the blood pressure waveform in the post-exercise period; and a processing unit configured to perform processing that is based on the indicator thus extracted.
  • Exercise causes a temporal change in a blood pressure waveform, and upon finishing the exercise, the blood pressure waveform gradually returns to its original state.
  • the amount of change in the blood pressure waveform and the returning time and the returning speed of the blood pressure waveform in such a case depend on the content of the exercise that the user performed, and characteristics related to the user's cardiac function. Therefore, it is possible to quantitatively evaluate the influence of exercise on the user's cardiac function by using characteristics of the blood pressure waveform in the pre-exercise period and the blood pressure waveform in the post-exercise period as with the configuration according to the present invention.
  • the indicator extraction unit may be configured to calculate the indicator based on a difference (the amount of change) between characteristics of the blood pressure waveform in the pre-exercise period and characteristics of the blood pressure waveform in the post-exercise period, or calculate the indicator based on an amount of time required for the characteristics of the blood pressure waveform, which has changed as a result of the exercise, to return to a state thereof in the pre-exercise period, or calculate the indicator based on a speed at which the characteristics of the blood pressure waveform, which has changed as a result of the exercise, return to a state thereof in the pre-exercise period. Also, these may be combined as appropriate.
  • the amount of change in a blood pressure waveform and the returning time and the returning speed of a blood pressure waveform depend on the content of the exercise that has been performed and on characteristics related to the user's cardiac function. Therefore, it is possible to appropriately evaluate the influence of exercise on the user's cardiac function by at least focusing on the amount of change in a blood pressure waveform, the returning time, and the returning speed.
  • the indicator extraction unit may be configured to use, as characteristics of blood pressure waveforms, at least one of an AI (Augmentation Index), a systolic blood pressure, a diastolic blood pressure, a mean blood pressure, a heart rate, and a difference in time between a systolic blood pressure and a late systolic pressure.
  • AI Application Index
  • a systolic blood pressure a diastolic blood pressure
  • a mean blood pressure a heart rate
  • a difference in time between a systolic blood pressure and a late systolic pressure may be used because they temporarily change (decrease or increase) as a result of exercise, and gradually return to their original states after the exercise.
  • the processing unit is configured to evaluate the degree of influence of the exercise on cardiac function, based on the indicator and an indicator that is related to the intensity and/or the duration of the exercise. Furthermore, it is preferable that the processing unit is configured to perform processing to output information regarding the degree of influence. By providing such information, it is possible to enable the user to grasp the exercise that he/she has performed and the influence of the exercise on the user's cardiac function in an objective and convincing manner.
  • the present invention can be interpreted as a biological information analysis device or system that is provided with at least one of the above-described configurations or at least one of the above-described functions.
  • the present invention can also be interpreted as a biological information analysis method that includes at least part of the above-described processing, or a program that causes a computer to execute such a method, or a computer-readable recording medium on which such a program is recorded in a non-transitory manner.
  • the present invention can be formed by combining the above-described configurations and the above-described kinds of processing with each other unless no technical inconsistency occurs.
  • FIG. 1 shows a schematic external configuration of a biological information analysis system 10 .
  • FIG. 2 is a block diagram showing a hardware configuration of the biological information analysis system 10 .
  • FIG. 3 is a cross-sectional view schematically showing a configuration of a blood pressure measurement unit 20 and a state in which measurement is performed.
  • FIG. 4 shows a blood pressure waveform that is measured by the blood pressure measurement unit 20 .
  • FIG. 5 is a block diagram illustrating processing that is performed by a biological information analysis device 1 .
  • FIG. 6 shows a waveform (a blood pressure waveform) of a pressure pulse wave from a radial artery corresponding to one heartbeat.
  • FIG. 7 is a flowchart for processing that is performed to evaluate an influence of exercise on cardiac function according to Example 1.
  • FIG. 8 is a diagram showing changes in blood pressure waveforms and a characteristic amount F of the blood pressure waveforms within a pre-exercise period, a target period (an exercise period), and a post-exercise period according to Example 1.
  • FIG. 9 shows an example of a chart for determining a result of evaluation according to Example 1.
  • FIG. 10 shows examples of pieces of evaluation result data according to Example 1.
  • FIG. 11 shows examples of indicators T and V in a case where AI values are used as values of the characteristic amount F of a blood pressure waveform according to Example 1.
  • FIG. 12 shows an example of an information output screen.
  • FIG. 13 shows an example of an information output screen.
  • FIG. 1 shows a schematic external configuration of a biological information analysis system 10 according to an embodiment of the present invention.
  • FIG. 1 shows a state in which the biological information analysis system 10 is worn on the left wrist.
  • the biological information analysis system 10 includes a main body 11 and a belt 12 that is fixed to the main body 11 .
  • the biological information analysis system 10 is a so-called wearable device, and is worn such that the main body 11 is in contact with the skin on the palm side of the wrist, and the main body 11 is located over a radial artery TD that lies beneath the skin.
  • the device is configured to be worn on the radial artery TD in the present embodiment, the device may be configured to be worn on another superficial artery.
  • FIG. 2 is a block diagram showing a hardware configuration of the biological information analysis system 10 .
  • the biological information analysis system 10 includes a measurement unit 2 and the biological information analysis device 1 .
  • the measurement unit 2 is a device that performs measurement to acquire information that is used to analyze biological information, and includes a blood pressure measurement unit 20 , a body movement measurement unit 21 , and an environment measurement unit 22 .
  • the configuration of the measurement unit 2 is not limited to that shown in FIG. 2 .
  • a unit that measures biological information other than blood pressure or body movement e.g. body temperature, blood-sugar level, or brain waves
  • body temperature e.g. body temperature, blood-sugar level, or brain waves
  • the biological information analysis device 1 is a device that analyzes biological information based on information acquired from the measurement unit 2 , and includes a control unit 23 , an input unit 24 , an output unit 25 , a communication unit 26 , and a storage unit 27 .
  • the units 20 to 27 are connected to each other so that signals can be exchanged between them via a local bus or other signal lines.
  • the biological information analysis system 10 also includes a power supply (a battery), which is not shown.
  • the blood pressure measurement unit 20 measures a pressure pulse wave from the radial artery TD by using a tonometry method.
  • the tonometry method is for forming a flat area in the artery TD by pressing the artery from the skin with appropriate pressure, adjusting the balance between the internal pressure and the external pressure of the artery, and non-invasively measuring the pressure pulse wave using a pressure sensor.
  • the body movement measurement unit 21 includes a tri-axis acceleration sensor, and measures the movement of the user's body (body movement) using this sensor.
  • the body movement measurement unit 21 may include a circuit that converts the format of an output from the tri-axis acceleration sensor into a format that is readable to the control unit 23 .
  • the environment measurement unit 22 measures environmental information that may affect mental and physical conditions of the user (in particular the blood pressure).
  • the environment measurement unit 22 may include, for example, an atmospheric temperature sensor, a humidity sensor, an illuminance sensor, an altitude sensor, a position sensor, and so on.
  • the environment measurement unit 22 may include a circuit that converts the format of outputs from these sensors and so on into a format that is readable to the control unit 23 .
  • the control unit 23 performs various kinds of processing, such as controlling each unit of the biological information analysis system 10 , acquiring data from the measurement unit 2 , storing the acquired data in the recording unit 27 , processing and analyzing data, and inputting and outputting data.
  • the control unit 23 includes a hardware processor (hereinafter referred to as the “CPU”) a ROM (Read Only Memory), a RAM (Random Access Memory), and so on. Processing that is performed by the control unit 23 , which will be described later, is realized by the CPU reading and executing a program stored in the ROM or the storage unit 27 .
  • the RAM functions as a work memory that is used by the control unit 23 when performing various kinds of processing.
  • Each of the constituent components of the embodiment such as a measurement unit, an indicator extraction unit, a processing unit, a determination unit, a risk database, an input unit, an output unit, a case database, and so on may be implemented as pieces of hardware in the biological information analysis system 10 .
  • the indicator extraction unit, the processing unit, and the determination unit may receive an executable program stored in the storage unit 27 , and execute the program.
  • the indicator extraction unit, the processing unit, and the determination unit may receive data from the blood pressure measurement unit 20 , the body movement measurement unit 21 , the environment measurement unit 22 , the input unit 24 , the output unit 25 , the communication unit 26 , the storage unit 27 , and so on as required.
  • Databases such as the risk database and the case database may be implemented using the storage unit 27 and so on, and store pieces of information that are arranged such that a data search and data accumulation can be easily performed.
  • the configuration, operations, and so on of the biological information analysis system 10 are disclosed in JP 2016-082069A. The contents of this disclosure are incorporated herein by reference.
  • the configuration, operations, and so on of the blood pressure measurement unit are disclosed in JP 2016-087003A. The contents of this disclosure are incorporated herein by reference.
  • the input unit 24 provides an operation interface for the user.
  • an operation button for example, an operation button, a switch, a touch panel, and so on may be used.
  • the output unit 25 provides an interface that outputs information to the user.
  • a display device such as a liquid crystal display
  • an audio output device or a beeper that outputs information using audio
  • an LED that outputs information by blinking
  • a vibration device that outputs information by vibrating, and so on may be used.
  • the communication unit 26 performs data communication with another device. Any data communication method such as a wireless LAN or Bluetooth (registered trademark) may be used.
  • the storage unit 27 is a storage medium that can store data and from which data can be read out, and stores programs that are to be executed by the control unit 23 , pieces of measurement data acquired from the measurement units, and various kinds of data acquired by processing the pieces of measurement data, and so on.
  • the storage unit 27 is a medium that accumulates pieces of information that are to be stored, through an electrical, magnetic, optical, mechanical, or chemical action. For example, a flash memory is used.
  • the storage unit 27 may be a portable unit such as a memory card, or built into the biological information analysis system 10 .
  • At least one unit or all units out of the body movement measurement unit 21 , environment measurement unit 22 , the control unit 23 , the input unit 24 , the output unit 25 , and the storage unit 27 may be configured as a device that is separate from the main body 11 . That is, as long as the blood pressure measurement unit 20 and the main body 11 that incorporates a circuit that controls the blood pressure measurement unit 20 are configured to be wearable on a wrist, the configurations of other units can be freely designed. If this is the case, the main body 11 cooperates with another unit via the communication unit 26 .
  • Various configurations can be conceived of.
  • control unit 23 the functions of the control unit 23 , the input unit 24 , and the output unit 25 may be realized using a smartphone application, and required data may be acquired from an activity monitor that has the functions of the body movement measurement unit 21 and the environment measurement unit 22 .
  • a sensor that measures biological information other than blood pressure may be provided.
  • a sleep sensor a pulse oximeter (an SpO2 sensor), a respiration sensor (a flow sensor), a blood-sugar level sensor, and the like may be combined.
  • the sensor (the blood pressure measurement unit 20 ) that measures blood pressure and the component (including the control unit 23 and so on) that performs processing to analyze blood pressure waveform data are provided in one device in the present embodiment, they may be provided in separate members.
  • the component (including the control unit 23 and so on) that performs processing to analyze biological information is referred to as a biological information analysis device, and the device that includes the combination of the measurement unit and the biological information analysis device is referred to as a biological information analysis system.
  • these names are given for descriptive purposes, and the measurement unit and the component that performs processing to analyze biological information may be referred to as a biological information analysis device as a whole, or other names may be used.
  • FIG. 3 is a cross-sectional view schematically showing the configuration of the blood pressure measurement unit 20 and a state in which measurement is performed.
  • the blood pressure measurement unit 20 includes a pressure sensor 30 and a pressurizing mechanism 31 for pressing the pressure sensor 30 against a wrist.
  • the pressure sensor 30 includes a plurality of pressure detection elements 300 .
  • the pressure detection elements 300 detect pressure and convert the pressure into an electrical signal.
  • elements that utilize a piezoresistive effect may be preferably used.
  • the pressurizing mechanism 31 includes, for example, an air bag and a pump that adjusts the internal pressure of the air bag. As a result of the control unit 23 controlling the pump to increase the internal pressure of the air bag, the air bag expands and the pressure sensor 30 is pressed against the surface of the skin.
  • the pressurizing mechanism 31 may be any mechanism as long as it can adjust the pressing force of the pressure sensor 30 applied to the surface of the skin, and is not limited to a mechanism that uses an air bag.
  • the control unit 23 controls the pressurizing mechanism 31 of the blood pressure measurement unit 20 to keep the pressing force of the pressure sensor 30 in an appropriate state (a tonometry state). Then, pressure signals detected by the pressure sensor 30 are sequentially acquired by the control unit 23 . Pressure signals acquired from the pressure sensor 30 are generated by digitizing analogue physical amounts (e.g. voltage values) output by the pressure detection elements 300 , through an A/D converter circuit or the like that employs a well-known technology. Preferable analogue values such as current values or resistance values may be employed as the analogue physical amounts, depending on the type of the pressure detection elements 300 .
  • analogue physical amounts e.g. voltage values
  • Preferable analogue values such as current values or resistance values may be employed as the analogue physical amounts, depending on the type of the pressure detection elements 300 .
  • Signal processing such as the aforementioned A/D conversion may be performed using a predetermined circuit provided in the blood pressure measurement unit 20 , or performed by another unit (not shown) provided between the blood pressure measurement unit 20 and the control unit 23 .
  • Each pressure signal acquired by the control unit 23 corresponds to an instantaneous value of the internal pressure of the radial artery TD. Therefore, it is possible to acquire time-series data regarding blood pressure waveforms by acquiring pressure signals with time granularity and continuity that make it possible to ascertain a blood pressure waveform for each heartbeat.
  • the control unit 23 stores the pressure signals sequentially acquired from the pressure sensor 30 , in the storage unit 27 , together with information regarding points in time at which the pressure signals were measured.
  • the control unit 23 may store the acquired pressure signals in the storage unit 27 without change, or store the pressure signals in the storage unit 27 after performing required signal processing on the pressure signals.
  • Required signal processing includes, for example, processing that is performed to calibrate each pressure signal such that the amplitude of the pressure signal matches the blood pressure value (e.g. the brachial blood pressure), processing that is performed to reduce or remove noise in each pressure signal, and so on.
  • FIG. 4 shows a blood pressure waveform measured by the blood pressure measurement unit 20 .
  • the horizontal axis indicates time and the vertical axis indicates blood pressure.
  • the sampling frequency may be set to any value, it is preferably set to be no less than 100 Hz so that characteristics of the shape of a waveform corresponding to one heartbeat can be reproduced.
  • the period of one heartbeat is approximately one second, and therefore approximately one hundred or more data points can be acquired on a waveform corresponding to one heartbeat.
  • the blood pressure measurement unit 20 according to the present embodiment is advantageous in terms of the following.
  • the blood pressure measurement unit 20 can measure a blood pressure waveform for each heartbeat. As a result, it is possible to acquire various indicators related to blood pressure, the state of the heart, cardiovascular risks, and so on, based on the characteristics of the shape of the blood pressure waveform. In addition, it is possible to monitor for instantaneous values of blood pressure. Therefore, it is possible to instantaneously detect a blood pressure surge (a sudden rise in the blood pressure value), and to detect changes in blood pressure and irregularities in a blood pressure waveform that may occur in a very short period of time (corresponding to one to several heartbeats) without missing them.
  • a blood pressure surge a sudden rise in the blood pressure value
  • a blood pressure meter As a portable blood pressure meter, a blood pressure meter that is to be worn on a wrist or an upper arm and employs an oscillometric method to measure blood pressure has come into practical use.
  • a conventional portable blood pressure meter can only measure the mean value of blood pressure based on changes in the internal pressure of a cuff during a period of several seconds to a dozen or so seconds corresponding to a plurality of heartbeats, and cannot acquire time-series data regarding a blood pressure waveform for each heartbeat, unlike the blood pressure measurement unit 20 according to the present embodiment.
  • the blood pressure measurement unit 20 can record time-series data regarding blood pressure waveforms. By acquiring time-series data regarding blood pressure waveforms, and, for example, discerning characteristics of the blood pressure waveform related to temporal changes, or performing a frequency analysis on the time-series data to extract a specific frequency component, it is possible to acquire various indicators related to blood pressure, the state of the heart, cardiovascular risks, and so on.
  • the device employs a portable (wearable) type configuration, and less burden is placed on the user during measurement. Therefore, continuous measurement for a long time, and even 24-hour blood pressure monitoring, can be relatively easily performed. Also, since the device is of a portable type, changes in not only blood pressure under resting conditions, but also an ambulatory blood pressure (for example, during daily life or exercise) can be measured. As a result, it is possible to grasp how blood pressure is affected by behaviours in daily life (such as sleeping, eating, commuting, working, and taking medicine) and exercise, for example.
  • the blood pressure measurement unit 20 can be easily combined or linked with other sensors. For example, it is possible to make an evaluation of a cause-effect relationship or a composite evaluation with information that can be acquired by other sensors (e.g. body movement, environmental information such as an atmospheric temperature, biological information such as SpO2 and respiration information).
  • other sensors e.g. body movement, environmental information such as an atmospheric temperature, biological information such as SpO2 and respiration information.
  • FIG. 5 is a block diagram illustrating processing that is performed by the biological information analysis device 1 .
  • the biological information analysis device 1 includes an indicator extraction unit 50 and a processing unit 51 .
  • processing performed by the indicator extraction unit 50 and the processing unit 51 may be realized by the control unit 23 executing a program that is required for the processing.
  • the program may be stored in the storage unit 27 .
  • the control unit 23 executes the required program, the subject program stored in the ROM or storage unit 27 is loaded to the RAM. Then, the control unit 23 interprets and executes the program loaded to the RAM, using the CPU, to control each constituent component.
  • At least one or all of the processing procedures executed by the indicator extraction unit 50 and the processing unit 51 may be realized using a circuit such as an ASIC or an FPGA.
  • at least one or all of the processing procedures executed by the indicator extraction unit 50 and the processing unit 51 may be realized using a computer (e.g. a smartphone, a tablet terminal, a personal computer, or a cloud server) that is separate from the main body 11 .
  • the indicator extraction unit 50 acquires time-series data regarding blood pressure waveforms, which have been consecutively measured by the blood pressure measurement unit 20 , from the storage unit 27 .
  • the indicator extraction unit 50 extracts, from the acquired time-series data regarding blood pressure waveforms, indicators that are related to characteristics of the blood pressure waveforms.
  • characteristics of a blood pressure waveform include, for example, characteristics of the shape of a blood pressure waveform corresponding to one heartbeat, temporal changes in a blood pressure waveform, and frequency components of a blood pressure waveform.
  • characteristics of a blood pressure waveform are not limited to those listed above.
  • the extracted indicators are output to the processing unit 51 .
  • characteristics and indicators regarding a blood pressure waveform there are various characteristics and indicators regarding a blood pressure waveform, and the characteristics and indicators that are to be extracted may be designed or selected as appropriate according to the purpose of processing that is to be performed by the processing unit 51 . Characteristics and indicators that can be extracted from measurement data regarding blood pressure waveforms according to the present embodiment will be described later in detail.
  • the indicator extraction unit 50 may use measurement data that has been acquired by the body movement measurement unit 21 and/or measurement data that has been acquired by the environment measurement unit 22 , in addition to measurement data regarding blood pressure waveforms. Also, although not shown in the drawings, pieces of measurement data that have been acquired by a sleep sensor, an SpO2 sensor, a respiration sensor (a flow sensor), a blood-sugar level sensor, and the like may be combined with one another. By performing complex analysis on a plurality of kinds of measurement data acquired by a plurality of sensors, it is possible to perform more advanced information analysis of a blood pressure waveform.
  • a resting state and a moving state a state when an atmospheric temperature is high and a state when it is low
  • a light sleep state and a deep sleep state a breathing state and an apnea state
  • the processing unit 51 receives the indicators extracted by the indicator extraction unit 50 .
  • the processing unit 51 performs processing that is based on the received indicators.
  • Various kinds of processing can be conceived of as processing that is based on the indicators.
  • the processing unit 51 may provide the values of the extracted indicators or changes in the values to a user, a doctor, a public health nurse, or the like to prompt the utilization of the indicators in the fields of health care, treatment, health guidance, and so on.
  • the processing unit 51 may estimate cardiovascular risks from the extracted indicators, or provide guidelines for health maintenance or risk mitigation.
  • the processing unit 51 may inform the user or his/her doctor, or perform control to prevent the user from performing an action that burdens his/her heart and so on, or to prevent a cardiovascular event from occurring.
  • FIG. 6 shows a waveform (a blood pressure waveform) of a pressure pulse wave from a radial artery corresponding to one heartbeat.
  • the horizontal axis indicates time t (msec) and the vertical axis indicates blood pressure BP (mmHg).
  • a blood pressure waveform is the waveform of a composite wave constituted by an “ejection wave” that is generated when the heart contracts and pumps out blood, and a “reflection wave” that is generated when an ejection wave is reflected at a branch point of a peripheral vessel or an artery.
  • the following shows examples of characteristic points that can be extracted from a blood pressure waveform corresponding to one heartbeat.
  • the indicator extraction unit 50 may use any algorithm to detect the above-described characteristic points.
  • the indicator extraction unit 50 may perform computations to obtain an nth order differential waveform of a blood pressure waveform, and detect the zero-crossing points to extract the characteristic points (the inflection points) of the blood pressure waveform (the points F 1 , F 2 , F 4 , F 5 , and F 6 can be detected from the first order differential waveform, and the point F 3 can be detected from the second order differential waveform or the fourth order differential waveform).
  • the indicator extraction unit 50 may read out, from the storage unit 27 , a waveform pattern on which the characteristic points have been arranged in advance, and perform fitting of the waveform pattern to the target blood pressure waveform to specify the respective positions of the characteristic points.
  • the indicator extraction unit 50 performs computations based on time t and pressure BP of each of the above-described characteristic points F 1 to F 6 , and can thus obtain various kinds of information (values, characteristic amounts, indicators, etc.) from the blood pressure waveform of one heartbeat.
  • information values, characteristic amounts, indicators, etc.
  • tx and BPx respectively represent time and blood pressure corresponding to a characteristic point Fx.
  • Basic statistics of these pieces of information can also be used as indicators.
  • Basic statistics include, for example, representative values (a mean value, a median value, a mode value, the maximum value, the minimum value, and so on) and the degree of scatter (dispersion, a standard deviation, a coefficient of variation, and so on).
  • Temporal changes in these pieces of information can also be used as indicators.
  • the indicator extraction unit 50 can also acquire an indicator called BRS (Baroreflex Sensitivity) by performing computations on pieces of heartbeat information.
  • BRS Baroreflex Sensitivity
  • This indicator indicates the ability to regulate blood pressure to be constant.
  • methods for calculating the indicator include a spontaneous sequence method. This is a method for only extracting a sequence in which the maximum blood pressure SBP and the pulse wave interval TA consecutively rise or fall over the period of three or more heartbeats in synchronization with each other, plotting the maximum blood pressure SBP and the pulse wave interval TA onto a two-dimensional plane, and defining the inclination of the regression line obtained through a least squares method as the BRS.
  • the use of the biological information analysis system 10 makes it is possible to acquire various kinds of information from blood pressure waveform data.
  • the biological information analysis system 10 need not implement all of the functions that are required to acquire all of the kinds of information described above.
  • the biological information analysis system 10 need only implement functions that are required to acquire necessary information, depending on the configuration of the biological information analysis system 10 , who the user is, the purpose of use, the location of use, and so on.
  • each function may be provided as a program module (a piece of application software), and the biological information analysis system 10 may employ a mechanism with which a function can be added by installing a necessary program module on the biological information analysis system 10 .
  • the following illustrates an example, which is a specific application, of the biological information analysis system 10 .
  • the present example relates to a method for evaluating and visualizing an influence of exercise on a user's cardiac function, based on time-series data regarding blood pressure waveforms.
  • the inventors of the present invention observed changes in blood pressure waveforms before and after exercise, and ascertained the following phenomena.
  • Exercise causes a temporal change in a blood pressure waveform, and upon the exercise being complete, the blood pressure waveform gradually returns to its original state.
  • the amount of change in a blood pressure waveform and the amount of time required to return to a pre-exercise blood pressure waveform (a returning speed) depend on the activity amount of exercise performed.
  • the amount of change in a blood pressure waveform, and the amount of time required to return to a pre-exercise blood pressure waveform (a returning speed) also depend on the user's cardiovascular characteristics.
  • the present example proposes an algorithm for evaluating the degree of influence of exercise on cardiac function based on time-series data regarding blood pressure waveforms.
  • a biological information analysis device 1 uses characteristic amounts extracted from a blood pressure waveform for each heartbeat, to evaluate changes in blood pressure waveforms before and after exercise, and estimate cardiovascular characteristics.
  • characteristic amounts of a blood pressure waveform that can be used include the AI (Augmentation Index), the systolic blood pressure SBP, the diastole blood pressure DBP, the mean blood pressure MAP, the heart rate PR, a time difference DTp between the systolic blood pressure SBP and the late systolic pressure SBP 2 (t 3 ⁇ t 2 in FIG. 6 ), and so on.
  • AI, SBP, DBP, and MAP among these characteristic amounts temporarily decrease as a result of exercise, and then gradually increase and return to their respective original values.
  • PR and DTp temporarily increase as a result of exercise, and then gradually decrease and return to their respective original states.
  • it is not possible to grasp such changes in the characteristics amounts from blood pressure data obtained by a blood pressure meter that employs an oscillometric method and cannot measure blood pressure waveforms, or blood pressure data measured in a resting state.
  • the indicator extraction unit 50 reads time-series data regarding blood pressure waveforms and time-series data regarding activity intensity from the storage unit 27 or another data storage (step 4800 ). Next, the indicator extraction unit 50 detects periods of time during which exercise has been performed, from the time-series data regarding activity intensity, and labels an exercise period that is to be the target of evaluation (step 4801 ). For example, a period of time that satisfies the following conditions (1) to (3) is labeled as the target of evaluation.
  • an Ex amount The amount of activity (an Ex amount) throughout an entire period of time is no less than a threshold value Eth.
  • an Ex amount is a value obtained by multiplying activity intensity (METs) by an activity time.
  • Non-exercise periods e.g. periods of time during which a state where activity intensity is no greater than 1 METs continues
  • Tth2 a time no less than a time
  • condition (2) may be determined based on, for example, another indicator related to exercise (e.g. statistics (a mean value, the maximum value, a mode value, and so on) of the intensity of exercise performed during the period of time) or calories consumed, instead of the activity amount.
  • the threshold value Tth1 is set to be a time that is at least longer than the minimum unit time for which activity intensity can be measured.
  • the threshold value Tth2 is set to be of a duration whereby exercise performed in other periods of time does not influence evaluation.
  • the threshold values Tth1, Tth2, and Eth used for the above-described determination processing are stored in the storage unit 27 in advance, for example.
  • target period an exercise period labelled as the target of evaluation is referred to as a “target period”, and the amount of activity in the target period is denoted as Ea, and the duration (length) of activity is denoted as Ta.
  • the indicator extraction unit 50 acquires, from time-series data regarding blood pressure waveforms, blood pressure waveform data corresponding to a non-exercise period that is immediately before the target period (referred to as a “pre-exercise period”) and blood pressure waveform data corresponding to a non-exercise period that is immediately after the target period (referred to as a “post-exercise period”) (step 4802 ).
  • the length of the pre-exercise period and the post-exercise period can be freely set (so as to be no greater than Tth2 at the maximum).
  • FIG. 8 shows changes in blood pressure waveforms and values of the characteristic amount F of the blood pressure waveforms within a pre-exercise period, a target period (an exercise period), and a post-exercise period.
  • FIG. 8 shows an example in which an AI value is used as the characteristic amount F of the blood pressure waveforms.
  • the indicator extraction unit 50 calculates a value F 1 , which is a characteristic amount F before exercise, based on blood pressure waveform data regarding the pre-exercise period (step 4803 ).
  • the value F 1 is a mean value, a mode value, a median value, or the like of the characteristic amount F of the pre-exercise period.
  • the indicator DF represents how much a blood pressure waveform has changed as a result of exercise performed in the target period, and can be used as an indicator that represents the influence of exercise on the user's cardiac function. Note that, in the case of a characteristic amount that increases as a result of exercise (e.g. PR or DTp), a maximum value F 2 of the characteristic amount F in the post-exercise period is to be calculated in step 4804 .
  • a characteristic amount that increases as a result of exercise e.g. PR or DTp
  • the processing unit 51 evaluates the degree of influence of the exercise on the cardiac function, based on the amount of activity Ea in the target period and the indicator DF (step S 4806 ).
  • one of the values Low (degree of influence: small), Mid (degree of influence: middle), and High (degree of influence: large) is output as a result of evaluation R.
  • the indicator DF is small (the amount of change in the characteristic amount F is small) despite the amount of activity Ea being large, an evaluation is made indicating that the cardiac function is less susceptible to the exercise.
  • FIG. 9 is an example of a chart for determining the result of evaluation R, which is used by the processing unit 51 .
  • the horizontal axis indicates the value of the indicator DF, and the vertical axis indicates the amount of activity (Ex). Note that criteria for evaluation and the determination chart are merely examples, and another method may be employed. Also, for example, soft clustering or evaluation using continuous values may be employed instead of three-level evaluation.
  • the processing unit 51 generates evaluation result data in which, for example, pieces of information regarding the target period (the start time of exercise, the amount of activity Ea, and the duration of activity Ta), pieces of information regarding the pre-exercise period and the post-exercise period (the characteristic amounts F 1 and F 2 ), the indicator (DF) indicating the degree of influence, and the result of evaluation (R) are associated with each other, and stores the evaluation result data in the storage unit 27 (step 4807 ). If a plurality of target periods have been extracted in step 4800 , the processing performed in steps 4802 to 4807 is repeated for each target period.
  • FIG. 10 shows examples of pieces of evaluation result data accumulated in the storage unit 27 .
  • the user can grasp how responsive his/her current cardiac function is to exercise, and can imagine the effect of exercise therapy, which will motivate the user to perform exercise regularly.
  • the user can be aware of exercise methods that are dangerous to them, and can select a type of exercise therapy that is suitable for the user's cardiovascular characteristics and is not excessive.
  • doctors and public health nurses can utilize such data to instruct the user to perform appropriate exercise therapy that is suited to the user's cardiovascular characteristics.
  • the following indicators may be used as an indicator indicating the influence of exercise on cardiac function.
  • FIG. 11 shows examples of the indicators T and V in a case where AI values are used as values of the characteristic amount F of a blood pressure waveform.
  • the indicators T and V are respectively calculated as follows.
  • T 2 denotes a point in time at which the characteristic amount F is at the minimum in the post-exercise period
  • F 2 denotes the value of the characteristic amount at the point in time T 2
  • T 3 denotes a point in time in the post-exercise period, at which the characteristic amount F returns to the value F 1 , which is the value before exercise
  • F 3 denotes the value of the characteristic amount at the point in time T 3 .
  • a certain margin may be provided in determining whether or not the characteristic amount F has been restored. For example, it is possible to determine that the characteristic amount F “has been restored” if the difference or ratio between the value F 1 of the characteristic amount before exercise and the value F 3 of the characteristic amount after exercise is within a predetermined range.
  • Te the end time of the target period (the point in time at which exercise ends) is denoted as Te
  • the indicators T and V may be obtained as follows:
  • the indicator DF it is also possible to evaluate the degree of influence of exercise on cardiac function by using the indicators T and V.
  • evaluating the degree of influence it is possible to use a plurality of indicators. For example, although a two-axis chart defined by the amount of activity Ea and the indicator DF is used in FIG. 9 , it is possible to determine the degree of influence by using a three-axis chart defined by the amount of activity Ea, the indicator DF, and the indicator T, or by using a four-axis chart defined by the amount of activity Ea, the indicator DF, the indicator T, and the indicator V. Note that a combination and the number of indicators used for determination may be freely selected.
  • the processing unit 51 may output information obtained through the above-described evaluation processing to the output unit 25 or an external display device or the like (not shown).
  • FIG. 12 shows an example of an information output screen output by the processing unit 51 .
  • the upper part shows a graph of information regarding the exercise period (the amount of activity Ea) and the blood pressure waveforms and the characteristic amount (the AI value) in the pre-exercise period and the post-exercise period, and the lower part shows a chart showing the result of evaluation (the star mark) of the exercise period.
  • the user can easily grasp the degree of influence of the exercise that he/she has performed, on his/her cardiac function.
  • FIG. 13 shows another example of an information output screen output by the processing unit 51 .
  • the results of evaluation (the star marks) of a plurality of exercises are displayed on the chart in chronological order.
  • the user can intuitively grasp changes in the degree of influence of the exercises that he/she has performed, on his/her cardiac function.
  • a biological information analysis device comprising:
  • a biological information analysis system comprising:
  • a biological information analysis method comprising:

Abstract

A biological information analysis device includes: an indicator extraction unit configured to acquire, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise, and extract an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and characteristics of the blood pressure waveform in the post-exercise period; and a processing unit configured to perform processing that is based on the indicator thus extracted.

Description

    TECHNICAL FIELD
  • The present invention relates to technology for acquiring useful information from a blood pressure waveform that has been measured.
    • RELATED ART
  • There is a known technology for measuring changes in the internal pressure of a radial artery and recording the shape of a pressure pulse wave (blood pressure waveform). Patent Document 1 (JP 2008-61824A) discloses that a blood pressure waveform is measured using a tonometry method, and pieces of information such as an AI (Augmentation Index) value, a pulse wave period, a baseline fluctuation rate, sharpness, and an ET (Ejection Time) are acquired from the blood pressure waveform. Also, Patent Document 2 (JP 2005-532111A) discloses that a blood pressure waveform is measured using a wristwatch-type blood pressure meter, in which a mean arterial pressure, a mean systolic pressure, a mean diastolic pressure, a mean systolic pressure indicator, and a mean diastolic pressure indicator are calculated from the blood pressure waveform, and an alert is output when any of these values deviates from a reference value.
    • RELATED ART DOCUMENTS Patent Documents
  • Patent Document 1: JP 2008-61824A
  • Patent Document 2: JP 2005-532111A
    • SUMMARY OF THE INVENTION Problem to be Solved by the Invention
  • It is known that exercise has the effect of improving blood pressure. However, it is necessary to continue exercise for a certain period of time to achieve the effect of lowering blood pressure. Therefore, there is a problem in that a user cannot imagine how much effect exercise has on the user, and the user cannot have high motivation to perform exercise. Also, too much exercise can actually be harmful to the user's body. However, the user does not know how much load is placed on his/her heart and so on by the exercise that he/she is performing, and therefore there is a problem in which the user cannot determine what exercise is risky for the user, or how much exercise is appropriate for the user.
  • The inventors of the present invention have been worked hard to develop a blood pressure measurement device that can accurately measure an ambulatory blood pressure waveform for each heartbeat, and to put such a device into practical use. Through experiments performed on subjects during the development phase, the inventors have found that various kinds of useful information can be extracted from data regarding ambulatory blood pressure waveforms that have been consecutively measured.
  • Therefore, the present invention aims to provide a novel technology for evaluating the degree of influence of exercise on cardiac function, based on data regarding blood pressure waveforms.
    • Means for Solving the Problems
  • To achieve the above-described aim, the present invention employs the following configurations.
  • A biological information analysis device according to the present invention is an biological information analysis device including: an indicator extraction unit configured to acquire, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise, and extract an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and characteristics of the blood pressure waveform in the post-exercise period; and a processing unit configured to perform processing that is based on the indicator thus extracted.
  • Exercise causes a temporal change in a blood pressure waveform, and upon finishing the exercise, the blood pressure waveform gradually returns to its original state. The amount of change in the blood pressure waveform and the returning time and the returning speed of the blood pressure waveform in such a case depend on the content of the exercise that the user performed, and characteristics related to the user's cardiac function. Therefore, it is possible to quantitatively evaluate the influence of exercise on the user's cardiac function by using characteristics of the blood pressure waveform in the pre-exercise period and the blood pressure waveform in the post-exercise period as with the configuration according to the present invention.
  • Specifically, the indicator extraction unit may be configured to calculate the indicator based on a difference (the amount of change) between characteristics of the blood pressure waveform in the pre-exercise period and characteristics of the blood pressure waveform in the post-exercise period, or calculate the indicator based on an amount of time required for the characteristics of the blood pressure waveform, which has changed as a result of the exercise, to return to a state thereof in the pre-exercise period, or calculate the indicator based on a speed at which the characteristics of the blood pressure waveform, which has changed as a result of the exercise, return to a state thereof in the pre-exercise period. Also, these may be combined as appropriate. As described above, the amount of change in a blood pressure waveform and the returning time and the returning speed of a blood pressure waveform depend on the content of the exercise that has been performed and on characteristics related to the user's cardiac function. Therefore, it is possible to appropriately evaluate the influence of exercise on the user's cardiac function by at least focusing on the amount of change in a blood pressure waveform, the returning time, and the returning speed.
  • The indicator extraction unit may be configured to use, as characteristics of blood pressure waveforms, at least one of an AI (Augmentation Index), a systolic blood pressure, a diastolic blood pressure, a mean blood pressure, a heart rate, and a difference in time between a systolic blood pressure and a late systolic pressure. These characteristics may be used because they temporarily change (decrease or increase) as a result of exercise, and gradually return to their original states after the exercise.
  • It is preferable that the processing unit is configured to evaluate the degree of influence of the exercise on cardiac function, based on the indicator and an indicator that is related to the intensity and/or the duration of the exercise. Furthermore, it is preferable that the processing unit is configured to perform processing to output information regarding the degree of influence. By providing such information, it is possible to enable the user to grasp the exercise that he/she has performed and the influence of the exercise on the user's cardiac function in an objective and convincing manner.
  • Note that the present invention can be interpreted as a biological information analysis device or system that is provided with at least one of the above-described configurations or at least one of the above-described functions. The present invention can also be interpreted as a biological information analysis method that includes at least part of the above-described processing, or a program that causes a computer to execute such a method, or a computer-readable recording medium on which such a program is recorded in a non-transitory manner. The present invention can be formed by combining the above-described configurations and the above-described kinds of processing with each other unless no technical inconsistency occurs.
    • Effects of the Invention
  • According to the present invention, it is possible to provide a novel technology for evaluating the degree of influence of exercise on cardiac function, based on data regarding blood pressure waveforms.
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a schematic external configuration of a biological information analysis system 10.
  • FIG. 2 is a block diagram showing a hardware configuration of the biological information analysis system 10.
  • FIG. 3 is a cross-sectional view schematically showing a configuration of a blood pressure measurement unit 20 and a state in which measurement is performed.
  • FIG. 4 shows a blood pressure waveform that is measured by the blood pressure measurement unit 20.
  • FIG. 5 is a block diagram illustrating processing that is performed by a biological information analysis device 1.
  • FIG. 6 shows a waveform (a blood pressure waveform) of a pressure pulse wave from a radial artery corresponding to one heartbeat.
  • FIG. 7 is a flowchart for processing that is performed to evaluate an influence of exercise on cardiac function according to Example 1.
  • FIG. 8 is a diagram showing changes in blood pressure waveforms and a characteristic amount F of the blood pressure waveforms within a pre-exercise period, a target period (an exercise period), and a post-exercise period according to Example 1.
  • FIG. 9 shows an example of a chart for determining a result of evaluation according to Example 1.
  • FIG. 10 shows examples of pieces of evaluation result data according to Example 1.
  • FIG. 11 shows examples of indicators T and V in a case where AI values are used as values of the characteristic amount F of a blood pressure waveform according to Example 1.
  • FIG. 12 shows an example of an information output screen.
  • FIG. 13 shows an example of an information output screen.
    •  EMBODIMENTS OF THE INVENTION
  • The following describes a preferred embodiment of the present invention with reference to the drawings. Note that the following descriptions of components may be modified as appropriate depending on the configuration of a device to which the present invention is applied, and on various conditions, and the scope of the present invention is not intended to be limited to the following descriptions.
    • Biological Information Analysis System
  • FIG. 1 shows a schematic external configuration of a biological information analysis system 10 according to an embodiment of the present invention. FIG. 1 shows a state in which the biological information analysis system 10 is worn on the left wrist. The biological information analysis system 10 includes a main body 11 and a belt 12 that is fixed to the main body 11. The biological information analysis system 10 is a so-called wearable device, and is worn such that the main body 11 is in contact with the skin on the palm side of the wrist, and the main body 11 is located over a radial artery TD that lies beneath the skin. Although the device is configured to be worn on the radial artery TD in the present embodiment, the device may be configured to be worn on another superficial artery.
  • FIG. 2 is a block diagram showing a hardware configuration of the biological information analysis system 10. In general, the biological information analysis system 10 includes a measurement unit 2 and the biological information analysis device 1. The measurement unit 2 is a device that performs measurement to acquire information that is used to analyze biological information, and includes a blood pressure measurement unit 20, a body movement measurement unit 21, and an environment measurement unit 22. However, note that the configuration of the measurement unit 2 is not limited to that shown in FIG. 2. For example, a unit that measures biological information other than blood pressure or body movement (e.g. body temperature, blood-sugar level, or brain waves) may be added. Also, any unit that is not used in the example described below is not an essential component, and may be omitted from the biological information analysis system 10. The biological information analysis device 1 is a device that analyzes biological information based on information acquired from the measurement unit 2, and includes a control unit 23, an input unit 24, an output unit 25, a communication unit 26, and a storage unit 27. The units 20 to 27 are connected to each other so that signals can be exchanged between them via a local bus or other signal lines. The biological information analysis system 10 also includes a power supply (a battery), which is not shown.
  • The blood pressure measurement unit 20 measures a pressure pulse wave from the radial artery TD by using a tonometry method. The tonometry method is for forming a flat area in the artery TD by pressing the artery from the skin with appropriate pressure, adjusting the balance between the internal pressure and the external pressure of the artery, and non-invasively measuring the pressure pulse wave using a pressure sensor.
  • The body movement measurement unit 21 includes a tri-axis acceleration sensor, and measures the movement of the user's body (body movement) using this sensor. The body movement measurement unit 21 may include a circuit that converts the format of an output from the tri-axis acceleration sensor into a format that is readable to the control unit 23.
  • The environment measurement unit 22 measures environmental information that may affect mental and physical conditions of the user (in particular the blood pressure). The environment measurement unit 22 may include, for example, an atmospheric temperature sensor, a humidity sensor, an illuminance sensor, an altitude sensor, a position sensor, and so on. The environment measurement unit 22 may include a circuit that converts the format of outputs from these sensors and so on into a format that is readable to the control unit 23.
  • The control unit 23 performs various kinds of processing, such as controlling each unit of the biological information analysis system 10, acquiring data from the measurement unit 2, storing the acquired data in the recording unit 27, processing and analyzing data, and inputting and outputting data. The control unit 23 includes a hardware processor (hereinafter referred to as the “CPU”) a ROM (Read Only Memory), a RAM (Random Access Memory), and so on. Processing that is performed by the control unit 23, which will be described later, is realized by the CPU reading and executing a program stored in the ROM or the storage unit 27. The RAM functions as a work memory that is used by the control unit 23 when performing various kinds of processing. Although acquisition of data from the measurement unit 2 and the storing of data in the storage unit 27 are performed by the control unit 23 in the present embodiment, it is possible to employ a configuration in which the measurement unit 2 directly stores (writes) data in the storage unit 27.
  • Each of the constituent components of the embodiment such as a measurement unit, an indicator extraction unit, a processing unit, a determination unit, a risk database, an input unit, an output unit, a case database, and so on may be implemented as pieces of hardware in the biological information analysis system 10. The indicator extraction unit, the processing unit, and the determination unit may receive an executable program stored in the storage unit 27, and execute the program. The indicator extraction unit, the processing unit, and the determination unit may receive data from the blood pressure measurement unit 20, the body movement measurement unit 21, the environment measurement unit 22, the input unit 24, the output unit 25, the communication unit 26, the storage unit 27, and so on as required. Databases such as the risk database and the case database may be implemented using the storage unit 27 and so on, and store pieces of information that are arranged such that a data search and data accumulation can be easily performed. Here, for example, the configuration, operations, and so on of the biological information analysis system 10 are disclosed in JP 2016-082069A. The contents of this disclosure are incorporated herein by reference. Also, the configuration, operations, and so on of the blood pressure measurement unit are disclosed in JP 2016-087003A. The contents of this disclosure are incorporated herein by reference.
  • The input unit 24 provides an operation interface for the user. For example, an operation button, a switch, a touch panel, and so on may be used.
  • The output unit 25 provides an interface that outputs information to the user. For example, a display device (such as a liquid crystal display) that outputs information using images, an audio output device or a beeper that outputs information using audio, an LED that outputs information by blinking, a vibration device that outputs information by vibrating, and so on may be used.
  • The communication unit 26 performs data communication with another device. Any data communication method such as a wireless LAN or Bluetooth (registered trademark) may be used.
  • The storage unit 27 is a storage medium that can store data and from which data can be read out, and stores programs that are to be executed by the control unit 23, pieces of measurement data acquired from the measurement units, and various kinds of data acquired by processing the pieces of measurement data, and so on. The storage unit 27 is a medium that accumulates pieces of information that are to be stored, through an electrical, magnetic, optical, mechanical, or chemical action. For example, a flash memory is used. The storage unit 27 may be a portable unit such as a memory card, or built into the biological information analysis system 10.
  • At least one unit or all units out of the body movement measurement unit 21, environment measurement unit 22, the control unit 23, the input unit 24, the output unit 25, and the storage unit 27 may be configured as a device that is separate from the main body 11. That is, as long as the blood pressure measurement unit 20 and the main body 11 that incorporates a circuit that controls the blood pressure measurement unit 20 are configured to be wearable on a wrist, the configurations of other units can be freely designed. If this is the case, the main body 11 cooperates with another unit via the communication unit 26. Various configurations can be conceived of. For example, the functions of the control unit 23, the input unit 24, and the output unit 25 may be realized using a smartphone application, and required data may be acquired from an activity monitor that has the functions of the body movement measurement unit 21 and the environment measurement unit 22. Also, a sensor that measures biological information other than blood pressure may be provided. For example, a sleep sensor, a pulse oximeter (an SpO2 sensor), a respiration sensor (a flow sensor), a blood-sugar level sensor, and the like may be combined.
  • Although the sensor (the blood pressure measurement unit 20) that measures blood pressure and the component (including the control unit 23 and so on) that performs processing to analyze blood pressure waveform data are provided in one device in the present embodiment, they may be provided in separate members. In the present embodiment, the component (including the control unit 23 and so on) that performs processing to analyze biological information is referred to as a biological information analysis device, and the device that includes the combination of the measurement unit and the biological information analysis device is referred to as a biological information analysis system. However, these names are given for descriptive purposes, and the measurement unit and the component that performs processing to analyze biological information may be referred to as a biological information analysis device as a whole, or other names may be used.
    • Measurement of Blood Pressure Waveform
  • FIG. 3 is a cross-sectional view schematically showing the configuration of the blood pressure measurement unit 20 and a state in which measurement is performed. The blood pressure measurement unit 20 includes a pressure sensor 30 and a pressurizing mechanism 31 for pressing the pressure sensor 30 against a wrist. The pressure sensor 30 includes a plurality of pressure detection elements 300. The pressure detection elements 300 detect pressure and convert the pressure into an electrical signal. For example, elements that utilize a piezoresistive effect may be preferably used. The pressurizing mechanism 31 includes, for example, an air bag and a pump that adjusts the internal pressure of the air bag. As a result of the control unit 23 controlling the pump to increase the internal pressure of the air bag, the air bag expands and the pressure sensor 30 is pressed against the surface of the skin. Note that the pressurizing mechanism 31 may be any mechanism as long as it can adjust the pressing force of the pressure sensor 30 applied to the surface of the skin, and is not limited to a mechanism that uses an air bag.
  • Upon the biological information analysis system 10 being worn on a wrist and activated, the control unit 23 controls the pressurizing mechanism 31 of the blood pressure measurement unit 20 to keep the pressing force of the pressure sensor 30 in an appropriate state (a tonometry state). Then, pressure signals detected by the pressure sensor 30 are sequentially acquired by the control unit 23. Pressure signals acquired from the pressure sensor 30 are generated by digitizing analogue physical amounts (e.g. voltage values) output by the pressure detection elements 300, through an A/D converter circuit or the like that employs a well-known technology. Preferable analogue values such as current values or resistance values may be employed as the analogue physical amounts, depending on the type of the pressure detection elements 300. Signal processing such as the aforementioned A/D conversion may be performed using a predetermined circuit provided in the blood pressure measurement unit 20, or performed by another unit (not shown) provided between the blood pressure measurement unit 20 and the control unit 23. Each pressure signal acquired by the control unit 23 corresponds to an instantaneous value of the internal pressure of the radial artery TD. Therefore, it is possible to acquire time-series data regarding blood pressure waveforms by acquiring pressure signals with time granularity and continuity that make it possible to ascertain a blood pressure waveform for each heartbeat. The control unit 23 stores the pressure signals sequentially acquired from the pressure sensor 30, in the storage unit 27, together with information regarding points in time at which the pressure signals were measured. The control unit 23 may store the acquired pressure signals in the storage unit 27 without change, or store the pressure signals in the storage unit 27 after performing required signal processing on the pressure signals. Required signal processing includes, for example, processing that is performed to calibrate each pressure signal such that the amplitude of the pressure signal matches the blood pressure value (e.g. the brachial blood pressure), processing that is performed to reduce or remove noise in each pressure signal, and so on.
  • FIG. 4 shows a blood pressure waveform measured by the blood pressure measurement unit 20. The horizontal axis indicates time and the vertical axis indicates blood pressure. Although the sampling frequency may be set to any value, it is preferably set to be no less than 100 Hz so that characteristics of the shape of a waveform corresponding to one heartbeat can be reproduced. Typically, the period of one heartbeat is approximately one second, and therefore approximately one hundred or more data points can be acquired on a waveform corresponding to one heartbeat.
  • The blood pressure measurement unit 20 according to the present embodiment is advantageous in terms of the following.
  • The blood pressure measurement unit 20 can measure a blood pressure waveform for each heartbeat. As a result, it is possible to acquire various indicators related to blood pressure, the state of the heart, cardiovascular risks, and so on, based on the characteristics of the shape of the blood pressure waveform. In addition, it is possible to monitor for instantaneous values of blood pressure. Therefore, it is possible to instantaneously detect a blood pressure surge (a sudden rise in the blood pressure value), and to detect changes in blood pressure and irregularities in a blood pressure waveform that may occur in a very short period of time (corresponding to one to several heartbeats) without missing them.
  • As a portable blood pressure meter, a blood pressure meter that is to be worn on a wrist or an upper arm and employs an oscillometric method to measure blood pressure has come into practical use. However, a conventional portable blood pressure meter can only measure the mean value of blood pressure based on changes in the internal pressure of a cuff during a period of several seconds to a dozen or so seconds corresponding to a plurality of heartbeats, and cannot acquire time-series data regarding a blood pressure waveform for each heartbeat, unlike the blood pressure measurement unit 20 according to the present embodiment.
  • The blood pressure measurement unit 20 can record time-series data regarding blood pressure waveforms. By acquiring time-series data regarding blood pressure waveforms, and, for example, discerning characteristics of the blood pressure waveform related to temporal changes, or performing a frequency analysis on the time-series data to extract a specific frequency component, it is possible to acquire various indicators related to blood pressure, the state of the heart, cardiovascular risks, and so on.
  • The device employs a portable (wearable) type configuration, and less burden is placed on the user during measurement. Therefore, continuous measurement for a long time, and even 24-hour blood pressure monitoring, can be relatively easily performed. Also, since the device is of a portable type, changes in not only blood pressure under resting conditions, but also an ambulatory blood pressure (for example, during daily life or exercise) can be measured. As a result, it is possible to grasp how blood pressure is affected by behaviours in daily life (such as sleeping, eating, commuting, working, and taking medicine) and exercise, for example.
  • Conventional products are types of devices that measure blood pressure under resting conditions, with an arm or a wrist fixed to a blood pressure measurement unit, and cannot measure changes in blood pressure in daily life or during exercise, unlike the biological information analysis system 10 according to the present embodiment.
  • The blood pressure measurement unit 20 can be easily combined or linked with other sensors. For example, it is possible to make an evaluation of a cause-effect relationship or a composite evaluation with information that can be acquired by other sensors (e.g. body movement, environmental information such as an atmospheric temperature, biological information such as SpO2 and respiration information).
    • Biological Information Analysis Device
  • FIG. 5 is a block diagram illustrating processing that is performed by the biological information analysis device 1. As shown in FIG. 5, the biological information analysis device 1 includes an indicator extraction unit 50 and a processing unit 51. In the present embodiment, processing performed by the indicator extraction unit 50 and the processing unit 51 may be realized by the control unit 23 executing a program that is required for the processing. The program may be stored in the storage unit 27. When the control unit 23 executes the required program, the subject program stored in the ROM or storage unit 27 is loaded to the RAM. Then, the control unit 23 interprets and executes the program loaded to the RAM, using the CPU, to control each constituent component. Note that at least one or all of the processing procedures executed by the indicator extraction unit 50 and the processing unit 51 may be realized using a circuit such as an ASIC or an FPGA. Alternatively, at least one or all of the processing procedures executed by the indicator extraction unit 50 and the processing unit 51 may be realized using a computer (e.g. a smartphone, a tablet terminal, a personal computer, or a cloud server) that is separate from the main body 11.
  • The indicator extraction unit 50 acquires time-series data regarding blood pressure waveforms, which have been consecutively measured by the blood pressure measurement unit 20, from the storage unit 27. The indicator extraction unit 50 extracts, from the acquired time-series data regarding blood pressure waveforms, indicators that are related to characteristics of the blood pressure waveforms. Here, characteristics of a blood pressure waveform include, for example, characteristics of the shape of a blood pressure waveform corresponding to one heartbeat, temporal changes in a blood pressure waveform, and frequency components of a blood pressure waveform. However, characteristics of a blood pressure waveform are not limited to those listed above. The extracted indicators are output to the processing unit 51. There are various characteristics and indicators regarding a blood pressure waveform, and the characteristics and indicators that are to be extracted may be designed or selected as appropriate according to the purpose of processing that is to be performed by the processing unit 51. Characteristics and indicators that can be extracted from measurement data regarding blood pressure waveforms according to the present embodiment will be described later in detail.
  • When obtaining indicators, the indicator extraction unit 50 may use measurement data that has been acquired by the body movement measurement unit 21 and/or measurement data that has been acquired by the environment measurement unit 22, in addition to measurement data regarding blood pressure waveforms. Also, although not shown in the drawings, pieces of measurement data that have been acquired by a sleep sensor, an SpO2 sensor, a respiration sensor (a flow sensor), a blood-sugar level sensor, and the like may be combined with one another. By performing complex analysis on a plurality of kinds of measurement data acquired by a plurality of sensors, it is possible to perform more advanced information analysis of a blood pressure waveform. For example, it is possible to classify pieces of data regarding blood pressure waveforms according to states of the user, such as a resting state and a moving state, a state when an atmospheric temperature is high and a state when it is low, a light sleep state and a deep sleep state, a breathing state and an apnea state, and so on. Alternatively, it is possible to extract information regarding the influence of body movement, an activity amount, activity intensity, a change in an atmospheric temperature, apnea, the user's breathing, etc. on blood pressure, and thus evaluate the cause-effect relationship, the correlation, etc. between pieces of measurement data.
  • The processing unit 51 receives the indicators extracted by the indicator extraction unit 50. The processing unit 51 performs processing that is based on the received indicators. Various kinds of processing can be conceived of as processing that is based on the indicators. For example, the processing unit 51 may provide the values of the extracted indicators or changes in the values to a user, a doctor, a public health nurse, or the like to prompt the utilization of the indicators in the fields of health care, treatment, health guidance, and so on. Alternatively, the processing unit 51 may estimate cardiovascular risks from the extracted indicators, or provide guidelines for health maintenance or risk mitigation. Furthermore, when an increase in the risk of a cardiac disease occurring is detected or predicted based on an indicator, the processing unit 51 may inform the user or his/her doctor, or perform control to prevent the user from performing an action that burdens his/her heart and so on, or to prevent a cardiovascular event from occurring.
    • Information Acquired from Blood Pressure Waveform
  • FIG. 6 shows a waveform (a blood pressure waveform) of a pressure pulse wave from a radial artery corresponding to one heartbeat. The horizontal axis indicates time t (msec) and the vertical axis indicates blood pressure BP (mmHg).
  • A blood pressure waveform is the waveform of a composite wave constituted by an “ejection wave” that is generated when the heart contracts and pumps out blood, and a “reflection wave” that is generated when an ejection wave is reflected at a branch point of a peripheral vessel or an artery. The following shows examples of characteristic points that can be extracted from a blood pressure waveform corresponding to one heartbeat.
      • A point F1 is the rising point of the pressure pulse wave. The point F1 corresponds to the ejection start point of the heart, i.e. the point at which the aortic valve opens.
      • A point F2 is a point at which the amplitude (the pressure) of the ejection wave is at the maximum (a first peak).
      • A point F3 is an inflection point that appears midway in a drop in the ejection wave, due to a reflection wave being superimposed.
      • A point F4 is the minimum point, which appears between the ejection wave and the reflection wave, and is also referred to as a notch. This point corresponds to the point at which the aortic valve closes.
      • A point F5 is the peak of the reflection wave (a second peak), which appears after the point F4.
      • A point F6 is the end point of one heartbeat, and corresponds to the ejection start point of the next heartbeat, i.e. the start point of the next heartbeat.
  • The indicator extraction unit 50 may use any algorithm to detect the above-described characteristic points. For example, the indicator extraction unit 50 may perform computations to obtain an nth order differential waveform of a blood pressure waveform, and detect the zero-crossing points to extract the characteristic points (the inflection points) of the blood pressure waveform (the points F1, F2, F4, F5, and F6 can be detected from the first order differential waveform, and the point F3 can be detected from the second order differential waveform or the fourth order differential waveform). Alternatively, the indicator extraction unit 50 may read out, from the storage unit 27, a waveform pattern on which the characteristic points have been arranged in advance, and perform fitting of the waveform pattern to the target blood pressure waveform to specify the respective positions of the characteristic points.
  • The indicator extraction unit 50 performs computations based on time t and pressure BP of each of the above-described characteristic points F1 to F6, and can thus obtain various kinds of information (values, characteristic amounts, indicators, etc.) from the blood pressure waveform of one heartbeat. The following are typical examples of information that can be acquired from a blood pressure waveform. Note that tx and BPx respectively represent time and blood pressure corresponding to a characteristic point Fx.
      • Pulse Wave Interval (Period of Heartbeat) TA=t6−t1
      • Heart Rate PR=1/TA
      • Pulse Wave Rising Time UT=t2−t1
      • Systole TS=t4−t1
      • Diastole TD=t6−t4
      • Reflection Wave Delay Time=t3−t1
      • Maximum Blood Pressure (Systolic Blood Pressure) SBP=BP2
      • Minimum Blood Pressure (Diastolic Blood Pressure) DBP=BP1
      • Mean Blood Pressure MAP=(Area of Blood Pressure Waveform from t1 to t6)/Period of Heartbeat TA
      • Mean Blood Pressure during Systole=(Area of Blood Pressure Waveform from t1 to t4)/Systole TS
      • Mean Blood Pressure during Diastole=(Area of Blood Pressure Waveform from t4 to t6)/Diastole TD
      • Pulse Pressure PP=Maximum Blood Pressure SBP−Minimum Blood Pressure DBP
      • Late Systolic Pressure SBP2=BP3
      • AI (Augmentation Index)=(Late Systolic Pressure SBP2−Minimum Blood Pressure DBP)/Pulse Pressure PP
  • Basic statistics of these pieces of information (values, characteristic amounts, and indicators) can also be used as indicators. Basic statistics include, for example, representative values (a mean value, a median value, a mode value, the maximum value, the minimum value, and so on) and the degree of scatter (dispersion, a standard deviation, a coefficient of variation, and so on). Temporal changes in these pieces of information (values, characteristic values, and indicators) can also be used as indicators.
  • In addition, the indicator extraction unit 50 can also acquire an indicator called BRS (Baroreflex Sensitivity) by performing computations on pieces of heartbeat information. This indicator indicates the ability to regulate blood pressure to be constant. Examples of methods for calculating the indicator include a spontaneous sequence method. This is a method for only extracting a sequence in which the maximum blood pressure SBP and the pulse wave interval TA consecutively rise or fall over the period of three or more heartbeats in synchronization with each other, plotting the maximum blood pressure SBP and the pulse wave interval TA onto a two-dimensional plane, and defining the inclination of the regression line obtained through a least squares method as the BRS.
  • As described above, the use of the biological information analysis system 10 according to the present embodiment makes it is possible to acquire various kinds of information from blood pressure waveform data. However, the biological information analysis system 10 need not implement all of the functions that are required to acquire all of the kinds of information described above. The biological information analysis system 10 need only implement functions that are required to acquire necessary information, depending on the configuration of the biological information analysis system 10, who the user is, the purpose of use, the location of use, and so on. Also, each function may be provided as a program module (a piece of application software), and the biological information analysis system 10 may employ a mechanism with which a function can be added by installing a necessary program module on the biological information analysis system 10.
  • The following illustrates an example, which is a specific application, of the biological information analysis system 10.
    • EXAMPLE 1
  • The present example relates to a method for evaluating and visualizing an influence of exercise on a user's cardiac function, based on time-series data regarding blood pressure waveforms.
  • Although it is known that exercise has the effect of improving blood pressure, it is difficult for the user to imagine how much of an effect exercise has on the user. Also, although too much exercise can actually be harmful to the user's body, it is difficult for the user to know how much of a load is placed on his/her heart and so on due to the exercise that he/she is performing.
  • During an experiment on the subject, the inventors of the present invention observed changes in blood pressure waveforms before and after exercise, and ascertained the following phenomena. (1) Exercise causes a temporal change in a blood pressure waveform, and upon the exercise being complete, the blood pressure waveform gradually returns to its original state. (2) The amount of change in a blood pressure waveform and the amount of time required to return to a pre-exercise blood pressure waveform (a returning speed) depend on the activity amount of exercise performed. (3) The amount of change in a blood pressure waveform, and the amount of time required to return to a pre-exercise blood pressure waveform (a returning speed) also depend on the user's cardiovascular characteristics. Based on such findings, the present example proposes an algorithm for evaluating the degree of influence of exercise on cardiac function based on time-series data regarding blood pressure waveforms.
  • A biological information analysis device 1 according to the present example uses characteristic amounts extracted from a blood pressure waveform for each heartbeat, to evaluate changes in blood pressure waveforms before and after exercise, and estimate cardiovascular characteristics. Examples of characteristic amounts of a blood pressure waveform that can be used include the AI (Augmentation Index), the systolic blood pressure SBP, the diastole blood pressure DBP, the mean blood pressure MAP, the heart rate PR, a time difference DTp between the systolic blood pressure SBP and the late systolic pressure SBP2 (t3−t2 in FIG. 6), and so on. AI, SBP, DBP, and MAP among these characteristic amounts temporarily decrease as a result of exercise, and then gradually increase and return to their respective original values. In contrast, PR and DTp temporarily increase as a result of exercise, and then gradually decrease and return to their respective original states. Note that it is not possible to grasp such changes in the characteristic amounts unless an ambulatory blood pressure waveform is accurately monitored for each heartbeat. In other words, it is not possible to grasp such changes in the characteristics amounts from blood pressure data obtained by a blood pressure meter that employs an oscillometric method and cannot measure blood pressure waveforms, or blood pressure data measured in a resting state.
  • The following describes processing according to the present example with reference to the flowchart shown in FIG. 7. Here, it is presumed that pieces of time-series data regarding blood pressure waveforms measured by the blood pressure measurement unit 20 and pieces of time-series data regarding activity intensity (METs) measured by the body movement measurement unit 21 are accumulated in the storage unit 27 or another data storage (which may be a cloud sever).
  • The indicator extraction unit 50 reads time-series data regarding blood pressure waveforms and time-series data regarding activity intensity from the storage unit 27 or another data storage (step 4800). Next, the indicator extraction unit 50 detects periods of time during which exercise has been performed, from the time-series data regarding activity intensity, and labels an exercise period that is to be the target of evaluation (step 4801). For example, a period of time that satisfies the following conditions (1) to (3) is labeled as the target of evaluation.
  • (1) Exercise (a state where activity intensity is greater than 1 METs) continues for a time Tth1 or longer. Not only METs but also another indicator that indicates activity intensity (e.g. METs×body weight) may be used to represent activity intensity.
  • (2) The amount of activity (an Ex amount) throughout an entire period of time is no less than a threshold value Eth. Here, an Ex amount (exercise amount) is a value obtained by multiplying activity intensity (METs) by an activity time.
  • (3) Non-exercise periods (e.g. periods of time during which a state where activity intensity is no greater than 1 METs continues) that have a duration no less than a time Tth2 are respectively present before and after the period of time.
  • Note that the condition (2) may be determined based on, for example, another indicator related to exercise (e.g. statistics (a mean value, the maximum value, a mode value, and so on) of the intensity of exercise performed during the period of time) or calories consumed, instead of the activity amount. The threshold value Tth1 is set to be a time that is at least longer than the minimum unit time for which activity intensity can be measured. Also, the threshold value Tth2 is set to be of a duration whereby exercise performed in other periods of time does not influence evaluation. The threshold values Tth1, Tth2, and Eth used for the above-described determination processing are stored in the storage unit 27 in advance, for example.
  • In the following description, an exercise period labelled as the target of evaluation is referred to as a “target period”, and the amount of activity in the target period is denoted as Ea, and the duration (length) of activity is denoted as Ta.
  • Next, the indicator extraction unit 50 acquires, from time-series data regarding blood pressure waveforms, blood pressure waveform data corresponding to a non-exercise period that is immediately before the target period (referred to as a “pre-exercise period”) and blood pressure waveform data corresponding to a non-exercise period that is immediately after the target period (referred to as a “post-exercise period”) (step 4802). The length of the pre-exercise period and the post-exercise period can be freely set (so as to be no greater than Tth2 at the maximum). FIG. 8 shows changes in blood pressure waveforms and values of the characteristic amount F of the blood pressure waveforms within a pre-exercise period, a target period (an exercise period), and a post-exercise period. FIG. 8 shows an example in which an AI value is used as the characteristic amount F of the blood pressure waveforms.
  • The indicator extraction unit 50 calculates a value F1, which is a characteristic amount F before exercise, based on blood pressure waveform data regarding the pre-exercise period (step 4803). For example, the value F1 is a mean value, a mode value, a median value, or the like of the characteristic amount F of the pre-exercise period. The indicator extraction unit 50 also calculates a minimum value F2 of the characteristic amount F in the post-exercise period, based on blood pressure waveform data regarding the post-exercise period (step 4804). Then, the indicator extraction unit 50 calculates an amount of change DF (=|F1−F2|) in characteristic amount (step 4805). The indicator DF represents how much a blood pressure waveform has changed as a result of exercise performed in the target period, and can be used as an indicator that represents the influence of exercise on the user's cardiac function. Note that, in the case of a characteristic amount that increases as a result of exercise (e.g. PR or DTp), a maximum value F2 of the characteristic amount F in the post-exercise period is to be calculated in step 4804.
  • Subsequently, the processing unit 51 evaluates the degree of influence of the exercise on the cardiac function, based on the amount of activity Ea in the target period and the indicator DF (step S4806). In the present example, one of the values Low (degree of influence: small), Mid (degree of influence: middle), and High (degree of influence: large) is output as a result of evaluation R. For example, if the indicator DF is small (the amount of change in the characteristic amount F is small) despite the amount of activity Ea being large, an evaluation is made indicating that the cardiac function is less susceptible to the exercise. FIG. 9 is an example of a chart for determining the result of evaluation R, which is used by the processing unit 51. The horizontal axis indicates the value of the indicator DF, and the vertical axis indicates the amount of activity (Ex). Note that criteria for evaluation and the determination chart are merely examples, and another method may be employed. Also, for example, soft clustering or evaluation using continuous values may be employed instead of three-level evaluation.
  • The processing unit 51 generates evaluation result data in which, for example, pieces of information regarding the target period (the start time of exercise, the amount of activity Ea, and the duration of activity Ta), pieces of information regarding the pre-exercise period and the post-exercise period (the characteristic amounts F1 and F2), the indicator (DF) indicating the degree of influence, and the result of evaluation (R) are associated with each other, and stores the evaluation result data in the storage unit 27 (step 4807). If a plurality of target periods have been extracted in step 4800, the processing performed in steps 4802 to 4807 is repeated for each target period.
  • FIG. 10 shows examples of pieces of evaluation result data accumulated in the storage unit 27. As a result of such pieces of evaluation result data being accumulated, it is possible to grasp to what extent exercise influences the user's cardiac function, in an objective manner. Consequently, for example, the user can grasp how responsive his/her current cardiac function is to exercise, and can imagine the effect of exercise therapy, which will motivate the user to perform exercise regularly. In addition, the user can be aware of exercise methods that are dangerous to them, and can select a type of exercise therapy that is suitable for the user's cardiovascular characteristics and is not excessive. Also, doctors and public health nurses can utilize such data to instruct the user to perform appropriate exercise therapy that is suited to the user's cardiovascular characteristics.
    • Modifications
  • In addition to the amount of change DF in the characteristic amount F, the following indicators may be used as an indicator indicating the influence of exercise on cardiac function.
      • The amount of time T required for the characteristic amount F that has changed as a result of exercise, to return to the state thereof in the pre-exercise period.
      • A speed V at which the characteristic amount F that has changed as a result of exercise returns to the state thereof in the pre-exercise period.
  • Both the indicators T and V indicate the resilience of the user's cardiac function. FIG. 11 shows examples of the indicators T and V in a case where AI values are used as values of the characteristic amount F of a blood pressure waveform. The indicators T and V are respectively calculated as follows.

  • T=T3−T2

  • V=|F3−F2|/|T3−T2|
  • Here, T2 denotes a point in time at which the characteristic amount F is at the minimum in the post-exercise period, and F2 denotes the value of the characteristic amount at the point in time T2. T3 denotes a point in time in the post-exercise period, at which the characteristic amount F returns to the value F1, which is the value before exercise, and F3 denotes the value of the characteristic amount at the point in time T3. Note that a certain margin may be provided in determining whether or not the characteristic amount F has been restored. For example, it is possible to determine that the characteristic amount F “has been restored” if the difference or ratio between the value F1 of the characteristic amount before exercise and the value F3 of the characteristic amount after exercise is within a predetermined range. Also, when the end time of the target period (the point in time at which exercise ends) is denoted as Te, the indicators T and V may be obtained as follows:

  • T=T3−Te

  • V=|F3−Fe|/|T3−Te|
  • where Fe denotes the value of the characteristic amount at the point in time Te.
  • As with the indicator DF, it is also possible to evaluate the degree of influence of exercise on cardiac function by using the indicators T and V. When evaluating the degree of influence, it is possible to use a plurality of indicators. For example, although a two-axis chart defined by the amount of activity Ea and the indicator DF is used in FIG. 9, it is possible to determine the degree of influence by using a three-axis chart defined by the amount of activity Ea, the indicator DF, and the indicator T, or by using a four-axis chart defined by the amount of activity Ea, the indicator DF, the indicator T, and the indicator V. Note that a combination and the number of indicators used for determination may be freely selected.
    • Example of Output
  • The processing unit 51 may output information obtained through the above-described evaluation processing to the output unit 25 or an external display device or the like (not shown). FIG. 12 shows an example of an information output screen output by the processing unit 51. The upper part shows a graph of information regarding the exercise period (the amount of activity Ea) and the blood pressure waveforms and the characteristic amount (the AI value) in the pre-exercise period and the post-exercise period, and the lower part shows a chart showing the result of evaluation (the star mark) of the exercise period. By looking at such a screen, the user can easily grasp the degree of influence of the exercise that he/she has performed, on his/her cardiac function. FIG. 13 shows another example of an information output screen output by the processing unit 51. The results of evaluation (the star marks) of a plurality of exercises (four times in the example shown in FIG. 13) are displayed on the chart in chronological order. By looking at such a screen, the user can intuitively grasp changes in the degree of influence of the exercises that he/she has performed, on his/her cardiac function.
  • The configurations according to the above-described embodiment and examples are no more than specific examples of configurations according to the present invention, and are not intended to limit the scope of the present invention. The present invention may employ various specific configurations without departing from the technical idea thereof.
  • The technical idea disclosed in the present description can be specified as the following aspects of the present invention.
    • Supplementary Note 1
  • A biological information analysis device comprising:
      • a hardware processor; and a memory that is configured to store a program,
      • wherein the hardware processor is configured to execute the program to
      • acquire, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise;
      • extract an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and the characteristics of the blood pressure waveform in the post-exercise period; and
      • perform processing that is based on the indicator thus extracted.
    Supplementary Note 2
  • A biological information analysis system comprising:
      • a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat; a hardware processor; and a memory that is configured to store a program,
      • wherein the hardware processor is configured to execute the program to
      • acquire, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise;
      • extract an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and the characteristics of the blood pressure waveform in the post-exercise period; and
      • perform processing that is based on the indicator thus extracted.
    Supplementary Note 3
  • A biological information analysis method comprising:
      • a step of acquiring, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise, using at least one hardware processor;
      • a step of extracting an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and the characteristics of the blood pressure waveform in the post-exercise period, using at least one hardware processor; and
      • a step of performing processing that is based on the indicator thus extracted, using at least one hardware processor.
    INDEX TO THE REFERENCE NUMERALS
    • 1 . . . biological information analysis device, 2 . . . measurement unit
    • 10 . . . biological information analysis system, 11 . . . main body, 12 . . . belt
    • 20 . . . blood pressure measurement unit, 21 . . . body movement measurement unit,
    • 22 . . . environment measurement unit, 23 . . . control unit, 24 . . . input unit, 25 . . . output unit, 26 . . . communication unit, 27 . . . storage unit
    • 30 . . . pressure sensor, 31 . . . pressurizing mechanism, 300 . . . pressure detection element
    • 50 . . . indicator extraction unit, 51 . . . processing unit

Claims (10)

1. A biological information analysis device comprising:
an indicator extraction unit configured to acquire, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise, and extract an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of a blood pressure waveform in the pre-exercise period and characteristics of a blood pressure waveform in the post-exercise period; and
a processing unit configured to perform processing that is based on the indicator thus extracted.
2. The biological information analysis device according to claim 1,
wherein the indicator extraction unit is configured to calculate the indicator based on a difference between the characteristics of the blood pressure waveform in the pre-exercise period and the characteristics of the blood pressure waveform in the post-exercise period.
3. The biological information analysis device according to claim 1,
wherein the indicator extraction unit is configured to calculate the indicator based on an amount of time required for the characteristics of the blood pressure waveform, which has changed as a result of the exercise, to return to a state thereof in the pre-exercise period.
4. The biological information analysis device according to claim 1,
wherein the indicator extraction unit is configured to calculate the indicator based on a speed at which the characteristics of the blood pressure waveform, which has changed as a result of the exercise, return to a state thereof in the pre-exercise period.
5. The biological information analysis device according to claim 1,
wherein the indicator extraction unit is configured to use, as characteristics of blood pressure waveforms, at least one of an AI (Augmentation Index), a systolic blood pressure, a diastolic blood pressure, a mean blood pressure, a heart rate, and a difference in time between a systolic blood pressure and a late systolic pressure.
6. The biological information analysis device according to claim 1,
wherein the processing unit is configured to evaluate the degree of influence of the exercise on cardiac function, based on the indicator and an indicator that is related to the intensity and/or the duration of the exercise.
7. The biological information analysis device according to claim 6,
wherein the processing unit is configured to perform processing to output information regarding the degree of influence.
8. A biological information analysis system comprising:
a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat; and
the biological information analysis device according to claim 1, the biological information analysis device being configured to analyze biological information, using data regarding blood pressure waveforms consecutively measured by the sensor.
9. A non-transitory computer-readable medium storing a program that causes a processor to function as the indicator extraction unit and the processing unit of the biological information analysis device according to claim 1.
10. A biological information analysis method comprising:
a step of acquiring, from time-series data regarding blood pressure waveforms consecutively measured by a sensor that is configured to be worn on a body part of a user and to be capable of non-invasively measuring a blood pressure waveform for each heartbeat, data regarding a blood pressure waveform in a pre-exercise period that is a period of time before the user performs exercise, and data regarding a blood pressure waveform in a post-exercise period that is a period of time after the user performs the exercise, and extracting an indicator indicating the influence of the exercise on the user's cardiac function, based on characteristics of the blood pressure waveform in the pre-exercise period and characteristics of the blood pressure waveform in the post-exercise period; and
a step of performing processing that is based on the indicator thus extracted.
US16/092,167 2016-04-15 2017-04-14 Biological information analysis device, system, and program Abandoned US20190110700A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016082463 2016-04-15
JP2016-082463 2016-04-15
PCT/JP2017/015284 WO2017179703A1 (en) 2016-04-15 2017-04-14 Biological information analysis device and system, and program

Publications (1)

Publication Number Publication Date
US20190110700A1 true US20190110700A1 (en) 2019-04-18

Family

ID=60041783

Family Applications (11)

Application Number Title Priority Date Filing Date
US16/092,060 Abandoned US20190159722A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,097 Active 2038-09-29 US11617516B2 (en) 2016-04-15 2017-04-14 Biological information analysis device, biological information analysis system, program, and biological information analysis method
US16/092,134 Abandoned US20190090818A1 (en) 2016-04-15 2017-04-14 Biological information analyzing device, system, and program
US16/092,136 Abandoned US20190117084A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,076 Abandoned US20190159723A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, program, and biological information analysis method
US16/092,159 Active 2039-03-03 US11246501B2 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,095 Abandoned US20190150755A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,126 Abandoned US20190159682A1 (en) 2016-04-15 2017-04-14 Biological information analysis device and system, and program
US16/092,151 Active US11363961B2 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,167 Abandoned US20190110700A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,113 Abandoned US20190159685A1 (en) 2016-04-15 2017-04-14 Biological information analyzing device, system, and program

Family Applications Before (9)

Application Number Title Priority Date Filing Date
US16/092,060 Abandoned US20190159722A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,097 Active 2038-09-29 US11617516B2 (en) 2016-04-15 2017-04-14 Biological information analysis device, biological information analysis system, program, and biological information analysis method
US16/092,134 Abandoned US20190090818A1 (en) 2016-04-15 2017-04-14 Biological information analyzing device, system, and program
US16/092,136 Abandoned US20190117084A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,076 Abandoned US20190159723A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, program, and biological information analysis method
US16/092,159 Active 2039-03-03 US11246501B2 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,095 Abandoned US20190150755A1 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program
US16/092,126 Abandoned US20190159682A1 (en) 2016-04-15 2017-04-14 Biological information analysis device and system, and program
US16/092,151 Active US11363961B2 (en) 2016-04-15 2017-04-14 Biological information analysis device, system, and program

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/092,113 Abandoned US20190159685A1 (en) 2016-04-15 2017-04-14 Biological information analyzing device, system, and program

Country Status (5)

Country Link
US (11) US20190159722A1 (en)
EP (11) EP3427653B1 (en)
JP (11) JP6687263B2 (en)
CN (11) CN109069035B (en)
WO (11) WO2017179693A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11882755B2 (en) 2019-04-12 2024-01-23 Semiconductor Energy Laboratory Co., Ltd. Display device and system

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11253205B2 (en) * 2017-08-16 2022-02-22 Seiko Epson Corporation Pulse pressure and blood pressure analysis device, pulse pressure and blood pressure analysis method, and program
JP7124460B2 (en) * 2018-05-31 2022-08-24 セイコーエプソン株式会社 Biological analysis device, biological analysis method and program
US11317873B2 (en) * 2017-08-16 2022-05-03 Seiko Epson Corporation Biological analysis device, biological analysis method, and program
US11116414B2 (en) * 2017-08-16 2021-09-14 Seiko Epson Corporation Biological analysis device, biological analysis method, and program
CN107550481A (en) * 2017-08-24 2018-01-09 京东方科技集团股份有限公司 A kind of portable equipment and blood pressure measuring method
CN109833037B (en) * 2017-11-29 2022-05-17 华为终端有限公司 Equipment for monitoring blood pressure state and computer readable storage medium
JP2019115602A (en) * 2017-12-27 2019-07-18 オムロンヘルスケア株式会社 Biological information measuring device, measurement control method, and program
JP6897558B2 (en) * 2017-12-27 2021-06-30 オムロンヘルスケア株式会社 Information processing equipment, information processing methods and information processing programs
WO2019138327A1 (en) * 2018-01-09 2019-07-18 Shankar Rohini Wearable ecg and auscultation monitoring system with sos and remote monitoring
JP7091701B2 (en) * 2018-02-22 2022-06-28 オムロンヘルスケア株式会社 Blood pressure measuring device, blood pressure measuring method and program, breathing support device
JP6626951B2 (en) * 2018-03-12 2019-12-25 パラマウントベッド株式会社 Electric furniture
EP3808278A4 (en) * 2018-06-05 2022-06-01 Kazuo Tani Blood flow volume measurement system
WO2020037599A1 (en) * 2018-08-23 2020-02-27 深圳迈瑞生物医疗电子股份有限公司 Medical device, apnea event monitoring method and apparatus
JP6988001B2 (en) * 2018-08-30 2022-01-05 オリンパス株式会社 Recording device, image observation device, observation system, observation system control method, and observation system operation program
CN111012323A (en) * 2018-10-10 2020-04-17 三星电子株式会社 Device for estimating blood pressure and device for supporting blood pressure estimation
WO2020096311A1 (en) 2018-11-06 2020-05-14 Samsung Electronics Co., Ltd. Electronic device and method for identifying occurrence of hypotension
CN109674474B (en) * 2018-11-30 2021-12-03 深圳和而泰智能控制股份有限公司 Sleep apnea recognition method, device and computer readable medium
CN109731314B (en) * 2019-01-25 2020-12-29 杨彬 Cerebral infarction rehabilitation training device based on high in clouds
JP7320807B2 (en) * 2019-02-14 2023-08-04 デルタ工業株式会社 Physical condition determination device and computer program
JP7225893B2 (en) * 2019-02-18 2023-02-21 オムロンヘルスケア株式会社 Blood pressure value analysis support device, blood pressure value analysis support system, blood pressure value analysis support method, and program
JP7127571B2 (en) * 2019-02-18 2022-08-30 オムロンヘルスケア株式会社 Blood pressure level change detection device, blood pressure level change detection method, and program
US20200289889A1 (en) 2019-03-11 2020-09-17 Rom Technologies, Inc. Bendable sensor device for monitoring joint extension and flexion
US11541274B2 (en) 2019-03-11 2023-01-03 Rom Technologies, Inc. System, method and apparatus for electrically actuated pedal for an exercise or rehabilitation machine
JP6871546B2 (en) * 2019-03-12 2021-05-12 群馬県 Detection method and detection device for detecting abnormalities in pulse pressure waveform
JP7326802B2 (en) * 2019-03-25 2023-08-16 オムロンヘルスケア株式会社 Measurement facilitator, method and program
JP7256049B2 (en) * 2019-03-25 2023-04-11 オムロンヘルスケア株式会社 Blood pressure-related information display device, blood pressure-related information display method, and program
US11904207B2 (en) 2019-05-10 2024-02-20 Rehab2Fit Technologies, Inc. Method and system for using artificial intelligence to present a user interface representing a user's progress in various domains
US11433276B2 (en) 2019-05-10 2022-09-06 Rehab2Fit Technologies, Inc. Method and system for using artificial intelligence to independently adjust resistance of pedals based on leg strength
US11801423B2 (en) 2019-05-10 2023-10-31 Rehab2Fit Technologies, Inc. Method and system for using artificial intelligence to interact with a user of an exercise device during an exercise session
US11957960B2 (en) 2019-05-10 2024-04-16 Rehab2Fit Technologies Inc. Method and system for using artificial intelligence to adjust pedal resistance
JP7328044B2 (en) * 2019-07-22 2023-08-16 マクセル株式会社 Detection device and detection method
KR102567952B1 (en) * 2019-09-11 2023-08-16 삼성전자주식회사 Apparatus and method for estimating bio-information
JP2021040969A (en) * 2019-09-11 2021-03-18 オムロンヘルスケア株式会社 Method for generating determination algorithm, determination algorithm, determination system, determination method, program, and recording medium
US11071597B2 (en) 2019-10-03 2021-07-27 Rom Technologies, Inc. Telemedicine for orthopedic treatment
US11701548B2 (en) 2019-10-07 2023-07-18 Rom Technologies, Inc. Computer-implemented questionnaire for orthopedic treatment
US11915816B2 (en) 2019-10-03 2024-02-27 Rom Technologies, Inc. Systems and methods of using artificial intelligence and machine learning in a telemedical environment to predict user disease states
US11955221B2 (en) 2019-10-03 2024-04-09 Rom Technologies, Inc. System and method for using AI/ML to generate treatment plans to stimulate preferred angiogenesis
US11955220B2 (en) 2019-10-03 2024-04-09 Rom Technologies, Inc. System and method for using AI/ML and telemedicine for invasive surgical treatment to determine a cardiac treatment plan that uses an electromechanical machine
US11282599B2 (en) 2019-10-03 2022-03-22 Rom Technologies, Inc. System and method for use of telemedicine-enabled rehabilitative hardware and for encouragement of rehabilitative compliance through patient-based virtual shared sessions
US20210142893A1 (en) 2019-10-03 2021-05-13 Rom Technologies, Inc. System and method for processing medical claims
US20210128080A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. Augmented reality placement of goniometer or other sensors
US20210127974A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. Remote examination through augmented reality
US11282608B2 (en) 2019-10-03 2022-03-22 Rom Technologies, Inc. Method and system for using artificial intelligence and machine learning to provide recommendations to a healthcare provider in or near real-time during a telemedicine session
US11325005B2 (en) 2019-10-03 2022-05-10 Rom Technologies, Inc. Systems and methods for using machine learning to control an electromechanical device used for prehabilitation, rehabilitation, and/or exercise
US11139060B2 (en) 2019-10-03 2021-10-05 Rom Technologies, Inc. Method and system for creating an immersive enhanced reality-driven exercise experience for a user
US11955222B2 (en) 2019-10-03 2024-04-09 Rom Technologies, Inc. System and method for determining, based on advanced metrics of actual performance of an electromechanical machine, medical procedure eligibility in order to ascertain survivability rates and measures of quality-of-life criteria
US11282604B2 (en) 2019-10-03 2022-03-22 Rom Technologies, Inc. Method and system for use of telemedicine-enabled rehabilitative equipment for prediction of secondary disease
US20210134458A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. System and method to enable remote adjustment of a device during a telemedicine session
US11337648B2 (en) 2020-05-18 2022-05-24 Rom Technologies, Inc. Method and system for using artificial intelligence to assign patients to cohorts and dynamically controlling a treatment apparatus based on the assignment during an adaptive telemedical session
US20210134432A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. Method and system for implementing dynamic treatment environments based on patient information
US11075000B2 (en) 2019-10-03 2021-07-27 Rom Technologies, Inc. Method and system for using virtual avatars associated with medical professionals during exercise sessions
US20210134425A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. System and method for using artificial intelligence in telemedicine-enabled hardware to optimize rehabilitative routines capable of enabling remote rehabilitative compliance
US20210134412A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. System and method for processing medical claims using biometric signatures
US20210134463A1 (en) 2019-10-03 2021-05-06 Rom Technologies, Inc. Systems and methods for remotely-enabled identification of a user infection
US11830601B2 (en) 2019-10-03 2023-11-28 Rom Technologies, Inc. System and method for facilitating cardiac rehabilitation among eligible users
US11961603B2 (en) 2019-10-03 2024-04-16 Rom Technologies, Inc. System and method for using AI ML and telemedicine to perform bariatric rehabilitation via an electromechanical machine
US11069436B2 (en) 2019-10-03 2021-07-20 Rom Technologies, Inc. System and method for use of telemedicine-enabled rehabilitative hardware and for encouraging rehabilitative compliance through patient-based virtual shared sessions with patient-enabled mutual encouragement across simulated social networks
US11270795B2 (en) 2019-10-03 2022-03-08 Rom Technologies, Inc. Method and system for enabling physician-smart virtual conference rooms for use in a telehealth context
US11887717B2 (en) 2019-10-03 2024-01-30 Rom Technologies, Inc. System and method for using AI, machine learning and telemedicine to perform pulmonary rehabilitation via an electromechanical machine
US11915815B2 (en) 2019-10-03 2024-02-27 Rom Technologies, Inc. System and method for using artificial intelligence and machine learning and generic risk factors to improve cardiovascular health such that the need for additional cardiac interventions is mitigated
US11515021B2 (en) 2019-10-03 2022-11-29 Rom Technologies, Inc. Method and system to analytically optimize telehealth practice-based billing processes and revenue while enabling regulatory compliance
US11515028B2 (en) 2019-10-03 2022-11-29 Rom Technologies, Inc. Method and system for using artificial intelligence and machine learning to create optimal treatment plans based on monetary value amount generated and/or patient outcome
US11101028B2 (en) 2019-10-03 2021-08-24 Rom Technologies, Inc. Method and system using artificial intelligence to monitor user characteristics during a telemedicine session
US11955223B2 (en) 2019-10-03 2024-04-09 Rom Technologies, Inc. System and method for using artificial intelligence and machine learning to provide an enhanced user interface presenting data pertaining to cardiac health, bariatric health, pulmonary health, and/or cardio-oncologic health for the purpose of performing preventative actions
US11923065B2 (en) 2019-10-03 2024-03-05 Rom Technologies, Inc. Systems and methods for using artificial intelligence and machine learning to detect abnormal heart rhythms of a user performing a treatment plan with an electromechanical machine
US11756666B2 (en) 2019-10-03 2023-09-12 Rom Technologies, Inc. Systems and methods to enable communication detection between devices and performance of a preventative action
US11317975B2 (en) 2019-10-03 2022-05-03 Rom Technologies, Inc. Method and system for treating patients via telemedicine using sensor data from rehabilitation or exercise equipment
US11826613B2 (en) 2019-10-21 2023-11-28 Rom Technologies, Inc. Persuasive motivation for orthopedic treatment
KR102605901B1 (en) * 2020-03-10 2023-11-23 삼성전자주식회사 Apparatus and method for estimating bio-information
JP7462300B2 (en) 2020-05-08 2024-04-05 公立大学法人北九州市立大学 BLOOD PRESSURE MEASURING DEVICE, BLOOD PRESSURE MEASURING SYSTEM, VEHICLE, AND BLOOD PRESSURE MEASURING METHOD
CN111528825A (en) * 2020-05-14 2020-08-14 浙江大学 Photoelectric volume pulse wave signal optimization method
JP6916573B1 (en) * 2020-06-01 2021-08-11 株式会社Ａｒｂｌｅｔ Information processing systems, servers, information processing methods and programs
WO2021246346A1 (en) * 2020-06-01 2021-12-09 株式会社Arblet Information processing system, server, information processing method, and program
CN111685749B (en) * 2020-06-18 2022-09-02 郑昕 Construction method of pulse pressure wave mathematical model
DE102020124582A1 (en) * 2020-09-22 2022-03-24 Drägerwerk AG & Co. KGaA Medical device for evaluating a pulsatile signal
JP2022080166A (en) * 2020-11-17 2022-05-27 旭化成メディカル株式会社 Heart beat information acquisition device and heart beat information acquisition program
JP2022121340A (en) * 2021-02-08 2022-08-19 阿部 真一 Calculating blood flow rate, blood vessel diameter, blood vessel flow resistance, heart load factor, and the like according to measurement result of blood pressure manometer and displaying them to blood pressure manometer
WO2022196144A1 (en) * 2021-03-18 2022-09-22 テルモ株式会社 Arterial pressure estimation device, arterial pressure estimation system, and arterial pressure estimation method
CN113555082B (en) * 2021-07-26 2023-06-16 无锡市第二人民医院 Intelligent guiding training method for respiratory function
JPWO2023021970A1 (en) * 2021-08-19 2023-02-23
WO2023048158A1 (en) * 2021-09-22 2023-03-30 国立大学法人電気通信大学 Sleep apnea syndrome determination device, sleep apnea syndrome determination method, and program
CN113995396B (en) * 2021-12-24 2022-04-15 北京乾合晶芯电子技术有限公司 Be applied to cardiovascular internal medicine's blood pressure monitor
CN115990001B (en) * 2023-03-21 2024-04-05 首都医科大学宣武医院 Wearable monitoring system, wearable device and storage medium

Family Cites Families (186)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649929A (en) * 1981-06-11 1987-03-17 Sri International Method and apparatus for diagnosis of coronary artery disease
US4365636A (en) 1981-06-19 1982-12-28 Medicon, Inc. Method of monitoring patient respiration and predicting apnea therefrom
NL9100150A (en) * 1991-01-29 1992-08-17 Tno METHOD FOR DETERMINING THE BATTLE VOLUME AND THE HEART MINUTE VOLUME OF THE HUMAN HEART.
US7081095B2 (en) 2001-05-17 2006-07-25 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
JP3219325B2 (en) 1992-11-05 2001-10-15 日本コーリン株式会社 Respiratory rate measuring device
US5836884A (en) * 1993-12-17 1998-11-17 Pulse Metric, Inc. Method for diagnosing, monitoring and treating hypertension and other cardiac problems
JP3595593B2 (en) 1995-03-01 2004-12-02 コーリンメディカルテクノロジー株式会社 Blood ejection function evaluation device
JP3583494B2 (en) 1995-03-01 2004-11-04 コーリンメディカルテクノロジー株式会社 Blood ejection function evaluation device
JPH08317912A (en) 1995-03-23 1996-12-03 Seiko Instr Inc Pulse rate meter
AUPN236595A0 (en) 1995-04-11 1995-05-11 Rescare Limited Monitoring of apneic arousals
DE69632116T2 (en) 1995-05-12 2004-08-19 Seiko Epson Corp. DEVICE FOR DIAGNOSTICING THE STATE OF THE LIVING ORGANISM AND CONTROL UNIT
CN1140582A (en) 1995-07-20 1997-01-22 阿兹里尔·佩雷尔 Method of assessing cardiovascular function
JP3794410B2 (en) 1995-09-13 2006-07-05 セイコーエプソン株式会社 Health condition management device
JP3794409B2 (en) 1995-09-13 2006-07-05 セイコーエプソン株式会社 Health condition management device
JP3641830B2 (en) 1995-11-01 2005-04-27 セイコーエプソン株式会社 Biological condition measuring device
US5941837A (en) 1995-12-18 1999-08-24 Seiko Epson Corporation Health management device and exercise support device
JPH09220207A (en) 1996-02-19 1997-08-26 Omron Corp Blood pressure calculation device
DE69735683T2 (en) 1996-03-22 2006-10-19 Seiko Epson Corp. Device for measuring the intensity of movement
CN1155332C (en) 1996-04-17 2004-06-30 精工爱普生株式会社 Arrhythmia detector
JP3876889B2 (en) * 1996-06-12 2007-02-07 セイコーエプソン株式会社 Body temperature measuring device
US6030342A (en) 1996-06-12 2000-02-29 Seiko Epson Corporation Device for measuring calorie expenditure and device for measuring body temperature
JP4096376B2 (en) * 1996-07-09 2008-06-04 セイコーエプソン株式会社 Relaxation instruction equipment
US5720292A (en) * 1996-07-31 1998-02-24 Medwave, Inc. Beat onset detector
US5772601A (en) 1996-08-26 1998-06-30 Colin Corporation Apparatus for evaluating cardiac function of living subject
DE69618457T2 (en) 1996-08-28 2002-09-12 Colin Corp Device for evaluating the heart function of a living being
US6081742A (en) 1996-09-10 2000-06-27 Seiko Epson Corporation Organism state measuring device and relaxation instructing device
US5865755A (en) * 1996-10-11 1999-02-02 Dxtek, Inc. Method and apparatus for non-invasive, cuffless, continuous blood pressure determination
US5980464A (en) 1996-12-19 1999-11-09 Colin Corporation Apparatus for evaluating exercise function of person
JPH10185639A (en) 1996-12-27 1998-07-14 Tokyo Gas Co Ltd Flowmeter
JP3870514B2 (en) 1997-10-31 2007-01-17 セイコーエプソン株式会社 Stroke volume detection device and cardiac function diagnosis device
US5865756A (en) 1997-06-06 1999-02-02 Southwest Research Institute System and method for identifying and correcting abnormal oscillometric pulse waves
JP3842390B2 (en) 1997-07-16 2006-11-08 元治 長谷川 Blood pressure measurement device and cardiac function analysis device
EP0947160B1 (en) 1997-08-26 2006-03-01 Seiko Epson Corporation Pulse wave diagnosing device
JP3882204B2 (en) 1997-11-19 2007-02-14 セイコーエプソン株式会社 Pulse wave detector
CN1326489C (en) 1997-11-20 2007-07-18 精工爱普生株式会社 Pulse wave diagnostic apparatus, blood pressure monitor, pulse shape monitor and pharmacologic effect moritor
JP3820719B2 (en) 1997-12-24 2006-09-13 セイコーエプソン株式会社 Biological condition measuring device
JP3921775B2 (en) * 1998-01-27 2007-05-30 オムロンヘルスケア株式会社 Blood pressure monitoring device
IL128482A (en) * 1999-02-11 2003-06-24 Ultrasis Internat 1993 Ltd Method and device for continuous analysis of cardiovascular activity of a subject
NZ521115A (en) 2000-03-02 2004-05-28 Itamar Medical Ltd Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
US7806831B2 (en) 2000-03-02 2010-10-05 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
US6955648B2 (en) 2000-09-29 2005-10-18 New Health Sciences, Inc. Precision brain blood flow assessment remotely in real time using nanotechnology ultrasound
US6918879B2 (en) * 2000-10-09 2005-07-19 Healthstats International Pte. Ltd. Method and device for monitoring blood pressure
SG94349A1 (en) 2000-10-09 2003-02-18 Healthstats Int Pte Ltd Method and device for monitoring blood pressure
JP2002224059A (en) 2001-01-31 2002-08-13 Omron Corp Electronic sphygmomanometer
JP2002224061A (en) * 2001-01-31 2002-08-13 Omron Corp Electronic sphygmomanometer
JP3495344B2 (en) 2001-05-16 2004-02-09 日本コーリン株式会社 Pressure pulse wave detector
JP4759860B2 (en) 2001-07-11 2011-08-31 セイコーエプソン株式会社 Anoxic work threshold detection device
US6773397B2 (en) 2001-10-11 2004-08-10 Draeger Medical Systems, Inc. System for processing signal data representing physiological parameters
US6730038B2 (en) 2002-02-05 2004-05-04 Tensys Medical, Inc. Method and apparatus for non-invasively measuring hemodynamic parameters using parametrics
US6805673B2 (en) 2002-02-22 2004-10-19 Datex-Ohmeda, Inc. Monitoring mayer wave effects based on a photoplethysmographic signal
TW570769B (en) 2002-04-26 2004-01-11 Chin-Yu Lin Method and device for measuring pulse signals for simultaneously obtaining pulse pressure and blood flow rate
US6869402B2 (en) 2002-08-27 2005-03-22 Precision Pulsus, Inc. Method and apparatus for measuring pulsus paradoxus
DE10243265A1 (en) 2002-09-17 2004-03-25 Andreas Nuske Heart condition diagnosis method is based on analysis of bioelectrical signals recorded using a measurement glove that has a pulse sensor and electronics with an evaluation algorithm stored in ROM
US8672852B2 (en) * 2002-12-13 2014-03-18 Intercure Ltd. Apparatus and method for beneficial modification of biorhythmic activity
US20050096557A1 (en) * 2003-01-08 2005-05-05 Frederick Vosburgh Noninvasive cardiovascular monitoring methods and devices
JP4025220B2 (en) 2003-03-03 2007-12-19 ▲苅▼尾 七臣 Blood pressure monitor and cardiovascular disease risk analysis program
US7524292B2 (en) 2003-04-21 2009-04-28 Medtronic, Inc. Method and apparatus for detecting respiratory disturbances
JP4327524B2 (en) 2003-07-03 2009-09-09 ▲苅▼尾 七臣 Blood pressure abnormality inspection device at load change
US7244225B2 (en) * 2003-10-07 2007-07-17 Cardiomedics, Inc. Devices and methods for non-invasively improving blood circulation
EP1711102A4 (en) * 2004-01-27 2009-11-04 Spirocor Ltd Method and system for cardiovascular system diagnosis
JP2005237472A (en) 2004-02-24 2005-09-08 七臣 ▲苅▼尾 Sphygmomanometry instrument
JP3987053B2 (en) * 2004-03-30 2007-10-03 株式会社東芝 Sleep state determination device and sleep state determination method
US7828711B2 (en) 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US20060047202A1 (en) 2004-09-02 2006-03-02 Elliott Stephen B Method and system of breathing therapy for reducing sympathetic predominance with consequent positive modification of hypertension
CN1284512C (en) * 2004-10-21 2006-11-15 中国人民解放军空军航空医学研究所 Digital medical information monitoring and control system for full ward
JP4752259B2 (en) 2004-12-10 2011-08-17 オムロンヘルスケア株式会社 Electronic blood pressure monitor and blood pressure measurement system
WO2006079829A1 (en) * 2005-01-27 2006-08-03 Uws Ventures Limited Phosphoglycerides for use in improving heart rate recovery and increasing exercise capacity
JP4342455B2 (en) 2005-02-03 2009-10-14 株式会社東芝 Health management device and health management system
US20060195035A1 (en) * 2005-02-28 2006-08-31 Dehchuan Sun Non-invasive radial artery blood pressure waveform measuring apparatus system and uses thereof
CA2602899A1 (en) * 2005-03-21 2006-09-28 Software Solutions Limited System for continuous blood pressure monitoring
US8423108B2 (en) * 2005-03-24 2013-04-16 Intelomed, Inc. Device and system that identifies cardiovascular insufficiency
DE102005014950A1 (en) * 2005-04-01 2006-10-12 Braun Gmbh Method for determining cardiovascular parameters and device and computer program product for carrying out the method
JP5687741B2 (en) 2005-04-22 2015-03-18 フクダ電子株式会社 Biological information output device and method, and biological information report
WO2006121455A1 (en) 2005-05-10 2006-11-16 The Salk Institute For Biological Studies Dynamic signal processing
CN1723839A (en) * 2005-07-21 2006-01-25 高春平 Method and device for testing health-index of individualized and three-D type
CN1903117A (en) * 2005-07-27 2007-01-31 孙德铨 Non penetration type system for measuring radial artery blood pressure wave and its application
US8277387B2 (en) * 2005-10-24 2012-10-02 Koninklijke Philips Electronics N.V. System and method for determining the blood pressure of a patient
JP2007117591A (en) 2005-10-31 2007-05-17 Konica Minolta Sensing Inc Pulse wave analyzer
EP1785088A1 (en) 2005-11-14 2007-05-16 Congener Wellness Corp. A system and method for the management and control of cardiovascular related diseases, such as hypertension
CN1985750B (en) * 2005-12-21 2011-03-23 深圳迈瑞生物医疗电子股份有限公司 Pulse wave detecting method and device by means of cardiac symbol signal
JP2007190275A (en) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd Respiration training device
US7607243B2 (en) * 2006-05-03 2009-10-27 Nike, Inc. Athletic or other performance sensing systems
JP4901309B2 (en) 2006-05-31 2012-03-21 株式会社デンソー Biological state detection device, control device, and pulse wave sensor mounting device
JP2008005964A (en) * 2006-06-28 2008-01-17 Omron Healthcare Co Ltd Apnea controller and program for apnea control
JP2008061824A (en) 2006-09-07 2008-03-21 Omron Healthcare Co Ltd Medical measuring instrument, biosignal waveform extraction method and biosignal waveform extraction program
US20080064965A1 (en) 2006-09-08 2008-03-13 Jay Gregory D Devices and methods for measuring pulsus paradoxus
CN100466968C (en) * 2006-09-29 2009-03-11 北京新兴阳升科技有限公司 Detection method with blood pressure monitor and korotkoff sound delaying and pulse wave conducting time signal generator
JP4789203B2 (en) * 2006-10-02 2011-10-12 フクダ電子株式会社 Blood pressure reflex function measuring device
US8652040B2 (en) * 2006-12-19 2014-02-18 Valencell, Inc. Telemetric apparatus for health and environmental monitoring
US9044136B2 (en) 2007-02-16 2015-06-02 Cim Technology Inc. Wearable mini-size intelligent healthcare system
US8047998B2 (en) 2007-04-17 2011-11-01 General Electric Company Non-invasive blood pressure determination method
DE102007020038A1 (en) 2007-04-27 2008-10-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Evidence of apnea with blood pressure dependent detected signals
US20080319327A1 (en) 2007-06-25 2008-12-25 Triage Wireless, Inc. Body-worn sensor featuring a low-power processor and multi-sensor array for measuring blood pressure
JP4714194B2 (en) 2007-08-09 2011-06-29 オムロンヘルスケア株式会社 Blood pressure measurement device
US20090124914A1 (en) 2007-11-08 2009-05-14 Kuo Terry B J Analysis system and a method for pulse diagnosis in chinese medicine
US20090156946A1 (en) 2007-12-13 2009-06-18 Welch Allyn, Inc. Blood pressure motion sensing
JP5045514B2 (en) 2008-03-19 2012-10-10 オムロンヘルスケア株式会社 Electronic blood pressure monitor
JP5151690B2 (en) 2008-05-27 2013-02-27 オムロンヘルスケア株式会社 Blood pressure information measuring device and index acquisition method
JP5211910B2 (en) 2008-07-23 2013-06-12 オムロンヘルスケア株式会社 Biological information management system and measuring instrument
JP5336803B2 (en) 2008-09-26 2013-11-06 株式会社東芝 Pulse wave measuring device
JP5185785B2 (en) * 2008-11-19 2013-04-17 オムロンヘルスケア株式会社 Health condition judgment device
EP2189111A1 (en) 2008-11-21 2010-05-26 Pulsion Medical Systems AG Apparatus and method for determining a physiologic parameter
CN101773387B (en) 2009-01-08 2011-12-14 香港中文大学 Body feeling network-based sleeveless driven pulse pressure measurement and automatic calibration device
JP2010200901A (en) * 2009-03-02 2010-09-16 Nippon Koden Corp Biological signal measuring apparatus
JP5209545B2 (en) 2009-03-09 2013-06-12 株式会社デンソー Biopsy device, program, and recording medium
US20100268097A1 (en) 2009-03-20 2010-10-21 Edwards Lifesciences Corporation Monitoring Peripheral Decoupling
US8057400B2 (en) * 2009-05-12 2011-11-15 Angiologix, Inc. System and method of measuring changes in arterial volume of a limb segment
KR101640498B1 (en) 2009-05-22 2016-07-19 삼성전자주식회사 Blood pressure estimating apparatus and method by using variable characteristic ratio
CN201409913Y (en) 2009-06-10 2010-02-24 吕景文 Individual physical index monitoring system
SG10201502886VA (en) 2009-08-13 2015-05-28 Hidetsugu Asanoi Device For Calculating Respiratory Waveform Information And Medical Device Using Respiratory Waveform Information
CN102043893A (en) * 2009-10-13 2011-05-04 北京大学 Disease pre-warning method and system
JP5536582B2 (en) 2009-10-22 2014-07-02 日本光電工業株式会社 Biological parameter display device
WO2011094487A2 (en) 2010-01-29 2011-08-04 Edwards Lifesciences Corporation Elimination of the effects of irregular cardiac cycles in the determination of cardiovascular parameters
US8668649B2 (en) * 2010-02-04 2014-03-11 Siemens Medical Solutions Usa, Inc. System for cardiac status determination
EP2364640A1 (en) 2010-03-11 2011-09-14 BIOTRONIK SE & Co. KG Monitoring device and method for operating a monitoring device
JP5504477B2 (en) * 2010-03-16 2014-05-28 国立大学法人富山大学 Fingertip pulse wave analyzer and vascular endothelial function evaluation system using the same
US8834378B2 (en) 2010-07-30 2014-09-16 Nellcor Puritan Bennett Ireland Systems and methods for determining respiratory effort
US8315812B2 (en) 2010-08-12 2012-11-20 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
EP2752156B1 (en) * 2011-01-24 2017-09-27 Act Medical Service Co., Ltd. Blood vessel pulse-wave measuring system
JP5605269B2 (en) * 2011-02-28 2014-10-15 セイコーエプソン株式会社 Beat detector
JP5623955B2 (en) * 2011-03-29 2014-11-12 シチズンホールディングス株式会社 Sphygmomanometer
EP2524647A1 (en) * 2011-05-18 2012-11-21 Alain Gilles Muzet System and method for determining sleep stages of a person
JP5738673B2 (en) 2011-05-24 2015-06-24 オムロンヘルスケア株式会社 Blood pressure measurement device
BR112014001283A2 (en) * 2011-07-18 2017-02-21 Critical Care Diagnostics Inc Cardiovascular disease treatment methods and prevention of the effectiveness of exercise therapy
JP2013031568A (en) 2011-08-02 2013-02-14 Tdk Corp Method and apparatus for monitoring respiration, and sphygmomanometer with respiration monitoring function
EP2755551B1 (en) 2011-09-16 2016-08-17 Koninklijke Philips N.V. Device and method for estimating the heart rate during motion
SG11201400904SA (en) 2011-09-30 2014-04-28 Somalogic Inc Cardiovascular risk event prediction and uses thereof
JP5927843B2 (en) 2011-10-28 2016-06-01 セイコーエプソン株式会社 Congestion determination device, pulse wave measurement device, and congestion determination method
US9049995B2 (en) * 2012-01-12 2015-06-09 Pacesetter, Inc. System and method for detecting pulmonary congestion based on stroke volume using an implantable medical device
WO2013113055A1 (en) 2012-01-30 2013-08-08 Campbell Duncan Islay Method and apparatus for non-invasive determination of cardiac output
JP5953878B2 (en) 2012-03-30 2016-07-20 富士通株式会社 State change detection method, program, and apparatus
US10405791B2 (en) * 2013-03-15 2019-09-10 Yingchang Yang Method and continuously wearable noninvasive apparatus for automatically detecting a stroke and other abnormal health conditions
CN102697506B (en) 2012-05-29 2014-11-26 广州乾华生物科技有限公司 Method and system for monitoring action response condition
JP5984088B2 (en) * 2012-06-15 2016-09-06 国立大学法人 東京大学 Noninvasive continuous blood pressure monitoring method and apparatus
JP2014014556A (en) 2012-07-10 2014-01-30 Omron Healthcare Co Ltd Electronic sphygmomanometer and sphygmomanometry method
JP6019854B2 (en) 2012-07-13 2016-11-02 セイコーエプソン株式会社 Blood pressure measuring device and parameter correction method for central blood pressure estimation
JP2015013635A (en) * 2012-12-27 2015-01-22 株式会社東海理化電機製作所 Tire position determination system
EP2759257B1 (en) 2013-01-25 2016-09-14 UP-MED GmbH Method, logic unit and system for determining a parameter representative for the patient's volume responsiveness
JP2014171589A (en) 2013-03-07 2014-09-22 Seiko Epson Corp Atrial fibrillation analyzation equipment and program
US9345436B2 (en) 2013-03-14 2016-05-24 HighDim GmbH Apparatus and methods for computing cardiac output of a living subject
US9949696B2 (en) 2013-03-14 2018-04-24 Tensys Medical, Inc. Apparatus and methods for computing cardiac output of a living subject via applanation tonometry
CN103126655B (en) 2013-03-14 2014-10-08 浙江大学 Non-binding goal non-contact pulse wave acquisition system and sampling method
CN103230268B (en) 2013-03-22 2016-02-03 浙江理工大学 A kind of human body detection device that can carry out remote monitoring
US10390761B2 (en) 2013-04-16 2019-08-27 Kyocera Corporation Device, device control method and control program, and system
CN104138253B (en) * 2013-05-11 2016-06-15 吴健康 A kind of noinvasive arteriotony method for continuous measuring and equipment
CN103230267B (en) 2013-05-14 2015-06-03 北京理工大学 Anti-movement-interference extraction method for pulse rates
US9314211B2 (en) 2013-07-31 2016-04-19 Omron Healthcare Co., Ltd. Blood pressure measurement device having function of determining rest condition of patient
CN103479343B (en) * 2013-09-27 2015-02-25 上海交通大学 Central aortic pressure detection system and method based on oscillating sphygmomanometer signals
JP6347097B2 (en) 2013-10-07 2018-06-27 セイコーエプソン株式会社 Portable device and heartbeat arrival time measurement control method
US20150164351A1 (en) * 2013-10-23 2015-06-18 Quanttus, Inc. Calculating pulse transit time from chest vibrations
US20150112208A1 (en) * 2013-10-23 2015-04-23 Quanttus, Inc. Medication management
JP5911840B2 (en) 2013-11-25 2016-04-27 株式会社カオテック研究所 Diagnostic data generation device and diagnostic device
US20150196209A1 (en) * 2014-01-15 2015-07-16 Microsoft Corporation Cardiovascular risk factor sensing device
CN104055496B (en) 2014-01-15 2016-04-20 中国航天员科研训练中心 A kind of method of estimation of the sports load level based on heart source property signal
CN103892811B (en) * 2014-01-22 2016-09-07 杭州优体科技有限公司 A kind of ambulatory blood pressure joint-detection and the system of analysis
CN104808776A (en) * 2014-01-24 2015-07-29 北京奇虎科技有限公司 Device and method for detecting continuous attaching of head-wearing intelligent device on human body
JP6282887B2 (en) 2014-02-28 2018-02-21 国立大学法人広島大学 Blood pressure measuring device and blood pressure measuring method
WO2015153569A1 (en) 2014-03-31 2015-10-08 The Regents Of The University Of Michigan Miniature piezoelectric cardiovascular monitoring system
WO2015162566A1 (en) * 2014-04-24 2015-10-29 Ecole Polytechnique Federale De Lausanne (Epfl) A method and a device for non invasive blood pressure measurement
WO2015178439A2 (en) 2014-05-20 2015-11-26 株式会社Ａｉｎｙ Device and method for supporting diagnosis of central/obstructive sleep apnea, and computer-readable medium having stored thereon program for supporting diagnosis of central/obstructive sleep apnea
JP6358865B2 (en) 2014-06-13 2018-07-18 株式会社デンソー Sphygmomanometer
CN104091080B (en) * 2014-07-14 2017-02-22 中国科学院合肥物质科学研究院 Intelligent bodybuilding guidance system and closed-loop guidance method thereof
CN107072594B (en) 2014-07-28 2020-11-06 S V Siu联合有限责任公司 Method and apparatus for assessing respiratory distress
WO2016017579A1 (en) * 2014-07-28 2016-02-04 シナノケンシ株式会社 Biological information reading device
CN105455797B (en) 2014-08-19 2020-01-07 南京茂森电子技术有限公司 Autonomic nerve heart regulation function measuring method and device
WO2016031196A1 (en) * 2014-08-27 2016-03-03 日本電気株式会社 Blood pressure determination device, blood pressure determination method, recording medium for recording blood pressure determination program, and blood pressure measurement device
CN104188639B (en) * 2014-09-10 2017-02-15 朱宇东 Ambulatory blood pressure continuous monitoring and real-time analysis system
JP6280487B2 (en) 2014-10-16 2018-02-14 東京エレクトロン株式会社 Substrate processing method and substrate processing apparatus
JP6366463B2 (en) 2014-10-31 2018-08-01 オムロンヘルスケア株式会社 Blood pressure measurement device
CN104352228A (en) 2014-11-10 2015-02-18 小米科技有限责任公司 Method and device for processing application program
CN104382569B (en) * 2014-12-08 2017-04-12 天津工业大学 Fiber-optic sensing intelligent garment and heart sound parameter processing methods thereof
CN104665799A (en) 2015-01-26 2015-06-03 周常安 Blood pressure managing device and blood pressure managing method
WO2016119656A1 (en) 2015-01-26 2016-08-04 周常安 Cardiovascular health monitoring device and method
CN104665821A (en) 2015-01-26 2015-06-03 周常安 Cardiovascular health monitoring device and cardiovascular health monitoring method
CN204618202U (en) 2015-03-11 2015-09-09 佛山职业技术学院 A kind of intelligent bangle of athlete's status data remote capture
CN204708829U (en) 2015-04-24 2015-10-21 吉林大学 A kind of wireless breathing, pulse monitoring device
CN104856661A (en) 2015-05-11 2015-08-26 北京航空航天大学 Wearable continuous blood pressure estimating system and method based on dynamic compensation of diastolic blood pressure
CN105030195A (en) 2015-06-02 2015-11-11 牛欣 Three-position and nine-indicator multi-information acquisition and recognition device based on finger feel pressure application and microarray sensing
CN104958064A (en) 2015-07-15 2015-10-07 四川宇峰科技发展有限公司 Wearable arteriosclerosis detector and pulse wave velocity detecting method
CN105054918B (en) 2015-07-28 2018-05-22 杭州暖芯迦电子科技有限公司 A kind of blood pressure computational methods and blood pressure instrument based on the pulse reflective wave transmission time
CN105078474A (en) 2015-08-21 2015-11-25 武汉苏酷科技有限公司 Blood glucose and blood pressure monitoring and control system
CN105266828A (en) 2015-09-05 2016-01-27 于清 Sports psychology index data acquisition analysis and processing device
CN204909471U (en) 2015-09-05 2015-12-30 于清 Acquisition and analysis processing apparatus of sports psychology index data
CN105361858B (en) 2015-12-10 2018-04-03 广东小天才科技有限公司 A kind of method and wearable device of blood pressure data processing
JP6631376B2 (en) 2016-04-15 2020-01-15 オムロンヘルスケア株式会社 Pulse wave detecting device, biological information measuring device, control method of pulse wave detecting device, and control program of pulse wave detecting device
US11076813B2 (en) 2016-07-22 2021-08-03 Edwards Lifesciences Corporation Mean arterial pressure (MAP) derived prediction of future hypotension

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11882755B2 (en) 2019-04-12 2024-01-23 Semiconductor Energy Laboratory Co., Ltd. Display device and system

Also Published As

Publication number Publication date
US20190125252A1 (en) 2019-05-02
CN108882872A (en) 2018-11-23
CN108882878A (en) 2018-11-23
CN109069035A (en) 2018-12-21
JPWO2017179696A1 (en) 2019-02-21
JP6679005B2 (en) 2020-04-15
JPWO2017179702A1 (en) 2019-02-21
CN109069013A (en) 2018-12-21
EP3430989A4 (en) 2019-10-30
US20190159682A1 (en) 2019-05-30
WO2017179693A1 (en) 2017-10-19
WO2017179695A1 (en) 2017-10-19
EP3440995B1 (en) 2021-06-16
EP3427651A1 (en) 2019-01-16
EP3427653A4 (en) 2019-12-11
US20190159685A1 (en) 2019-05-30
JPWO2017179699A1 (en) 2019-02-21
EP3427651A4 (en) 2019-12-11
EP3427655A1 (en) 2019-01-16
EP3427648A4 (en) 2019-11-27
CN109069035B (en) 2021-09-28
US20190159722A1 (en) 2019-05-30
CN108882869A (en) 2018-11-23
US20190150755A1 (en) 2019-05-23
EP3427649A1 (en) 2019-01-16
JP6721156B2 (en) 2020-07-08
US11617516B2 (en) 2023-04-04
CN108882873B (en) 2021-08-06
EP3427650A1 (en) 2019-01-16
EP3427648A1 (en) 2019-01-16
US20190175027A1 (en) 2019-06-13
EP3427653B1 (en) 2021-03-31
JP6721153B2 (en) 2020-07-08
EP3427656A1 (en) 2019-01-16
JP6721155B2 (en) 2020-07-08
US20190117084A1 (en) 2019-04-25
JPWO2017179700A1 (en) 2019-02-21
US20190159723A1 (en) 2019-05-30
US20190090818A1 (en) 2019-03-28
EP3427652A1 (en) 2019-01-16
EP3427649B1 (en) 2021-03-10
CN108882873A (en) 2018-11-23
EP3427653A1 (en) 2019-01-16
EP3427655A4 (en) 2019-12-04
EP3430989A1 (en) 2019-01-23
EP3427650A4 (en) 2019-12-11
EP3430989B1 (en) 2021-06-09
EP3427656A4 (en) 2019-12-11
CN108882867B (en) 2021-12-07
JPWO2017179703A1 (en) 2019-02-28
WO2017179703A1 (en) 2017-10-19
WO2017179696A1 (en) 2017-10-19
JP6679051B2 (en) 2020-04-15
CN108882869B (en) 2021-03-23
CN108882868A (en) 2018-11-23
CN108882870B (en) 2021-08-13
CN108882868B (en) 2021-05-18
JPWO2017179694A1 (en) 2019-02-21
JPWO2017179701A1 (en) 2019-02-21
JP6659831B2 (en) 2020-03-04
EP3427652A4 (en) 2019-12-04
US20190117095A1 (en) 2019-04-25
EP3427654A1 (en) 2019-01-16
CN108882867A (en) 2018-11-23
EP3427656B1 (en) 2023-03-29
WO2017179694A1 (en) 2017-10-19
JP6687263B2 (en) 2020-04-22
CN108882877A (en) 2018-11-23
JPWO2017179693A1 (en) 2019-02-21
EP3440995A1 (en) 2019-02-13
JPWO2017179698A1 (en) 2019-02-21
WO2017179699A1 (en) 2017-10-19
CN109069013B (en) 2021-09-14
WO2017179698A1 (en) 2017-10-19
CN108882871B (en) 2021-04-16
CN108882870A (en) 2018-11-23
JP6679006B2 (en) 2020-04-15
JP6721154B2 (en) 2020-07-08
WO2017179700A1 (en) 2017-10-19
EP3427655B1 (en) 2021-03-10
EP3427654A4 (en) 2019-12-11
WO2017179701A1 (en) 2017-10-19
JPWO2017179697A1 (en) 2019-02-21
US11363961B2 (en) 2022-06-21
CN108882871A (en) 2018-11-23
EP3427652B1 (en) 2021-06-09
EP3427650B1 (en) 2021-06-23
JP6835395B2 (en) 2021-02-24
US11246501B2 (en) 2022-02-15
EP3440995A4 (en) 2020-02-19
JPWO2017179695A1 (en) 2019-02-21
WO2017179702A1 (en) 2017-10-19
CN108882878B (en) 2021-04-23
CN108882872B (en) 2021-07-20
EP3427649A4 (en) 2019-10-30
JP6659830B2 (en) 2020-03-04
CN108882877B (en) 2023-11-03
WO2017179697A1 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
US20190110700A1 (en) Biological information analysis device, system, and program

Legal Events

Date Code Title Description
AS Assignment

Owner name: OMRON CORPORATION, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAKAJIMA, HIROSHI;WADA, HIROTAKA;TSUCHIYA, NAOKI;AND OTHERS;SIGNING DATES FROM 20180903 TO 20180919;REEL/FRAME:047220/0045

Owner name: OMRON HEALTHCARE CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAKAJIMA, HIROSHI;WADA, HIROTAKA;TSUCHIYA, NAOKI;AND OTHERS;SIGNING DATES FROM 20180903 TO 20180919;REEL/FRAME:047220/0045

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION COUNTED, NOT YET MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION